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ABSTRACT 
As obligate intracellular parasites, viruses have to explore and modulate cellular pathways for 
their survival. Mechanistic studies of virus–host interactions provide a better understanding of 
viral infection and cellular responses and help to identify potential targets for therapeutic 
intervention. Alphaviruses, a group of small enveloped viruses with positive-sense, single-
stranded RNA genomes, are transmitted by mosquitoes and pose threats to human health. 
Semliki Forest virus (SFV) belongs to this group and has been extensively studied as a model 
virus for alphaviruses. Infection with alphaviruses, such as the important human pathogens 
chikungunya virus (CHIKV) or Ross River virus (RRV), is characterized by high fever, rash 
and debilitating joint pain, which can last for months or even years. The recent outbreaks and 
expanding spread of CHIKV in many tropical regions of the world as well as the continuous 
endemic of RRV in Australasia highlighted the significance of alphavirus research. 
Stress granules (SGs) are cytoplasmic aggregates of non-translated messenger 
ribonucleoprotein particles (mRNPs) that can be induced by many types of environmental 
stress, including viral infection. RNA processing bodies (P-bodies) are cytoplasmic aggregates 
of translationally silent mRNA and proteins involved in mRNA decay and translation 
repression. Unlike SGs, P-bodies are constitutively present in the cytoplasm under normal 
conditions. Both granules can actively respond to environmental stress and associate with each 
other under certain conditions. The PI3K–Akt–mTOR pathway plays important roles in 
regulating the transition between cell anabolism and catabolism, responding to changes in the 
cellular environment. Proper responses of SGs, P-bodies or the PI3K–Akt–mTOR pathway are 
seen as important adaption for cell survival under stress conditions.  
In this thesis, it was investigated how alphaviruses (more specifically, Old World alphaviruses 
such as SFV, CHIKV and RRV) exploit the SG nucleating protein G3BP, P-bodies and the 
PI3K–Akt–mTOR pathway upon infection. 
Previous studies have demonstrated that the alphavirus non-structural protein nsP3 binds to the 
SG nucleating protein G3BP via its two FGDF motifs to block SG induction. In paper I, we 
compared the two FGDF motifs in nsP3 with respect to their contribution to G3BP binding. 
The three-dimensional structure of G3BP1 bound to an SFV nsP3-derived peptide (nsP3-25, 
containing two FGDF motifs) revealed a poly-assembly of G3BP1 dimers inter-connected by 
nsP3-25. Both in vitro and in vivo binding studies demonstrated a hierarchical binding mode 
of the duplicate FGDF motifs to G3BP. SFV mutants lacking either of the FGDF motifs failed 
to bind levels of G3BP necessary for efficient replication, clearly demonstrating that both intact 
FGDF motifs are required for efficient virus replication. The hierarchical binding mode of two 
FGDF motifs was also observed for CHIKV nsP3. Growth curves showed that the two intact 
FGDF motifs are critical for viral replication. Mutation of both FGDF motifs was lethal to 
CHIKV. These results highlight a conserved molecular mechanism of virus-induced G3BP 
modulation.  
In paper II, we described that P-bodies are disassembled or reduced in number after infection 
with SFV or CHIKV in various cell lines. Disassembly of P-bodies occurs at an early stage (3–
4h) post infection and is independent of viral structural protein expression. Similar to SGs, P-
bodies could not be re-introduced by a second stress (sodium arsenite) in infected cells. 
However, formation of SGs or communication between P-bodies and SGs is not necessary for 
P-body disassembly, since P-bodies were still disassembled to a similar extent upon infection 
of cells incapable of forming SGs. Studies of the translation status by ribopuromycylation 
showed that P-body disassembly is independent of host translation shutoff, which requires the 
phosphorylation of the eukaryotic initiation factor eIF2a in cells infected with SFV or CHIKV. 
By labelling newly synthesized RNA with bromo-UTP, we observed that the timing of host 
transcription shutoff correlated with P-body disassembly, occurring at the same stage (3–4h) 
after infection. However, inhibition of transcription with actinomycin D (ActD) failed to 
disassemble P-bodies as efficiently as the viruses did. Interestingly, the block of nuclear import 
in non-infected cells with importazole led to an efficient P-body loss. These results reveal that 
P-bodies are disassembled independently of SG formation at early stages of Old World 
alphavirus infection and that nuclear import is involved in the dynamics of P-bodies. 
Infection with SFV hyperactivates the PI3K–Akt–mTOR pathway. In paper III, we show that 
a tyrosine residue in the sequence context YEPM in nsP3 of SFV is pivotal for this phenotype. 
When cells were infected with SFV carrying mutations that affect this motif, such as the 
replacement of the YEPM tyrosine by phenylalanine (SFV-YF), Akt activation was 
significantly reduced and delayed in comparison to wildtype SFV infection. Ectopically 
expressed nsP3 of SFV-WT but not SFV-YF activated the pathway, but only when provided 
with a membrane anchor. Co-immunoprecipitation experiments revealed that nsP3 of SFV-
WT, but not SFV-YF, bound to the regulatory subunit p85 of PI3K, dependent on both the 
tyrosine of nsP3 and the SH2 domains of p85, which specifically interact with phosphorylated 
tyrosines in YXXM motifs. This indicates tyrosine phosphorylation of SFV nsP3. A similar 
YETM motif was identified and characterized in RRV nsP3. Similar to SFV, RRV-WT 
hyperactivated the PI3K–Akt–mTOR pathway while the mutant RRV-YF, in which the 
YXXM tyrosine in nsP3 was replaced by phenylalanine, failed to do so.. Complementary 
experiments showed that infection of cells with SFV or RRV reprograms cellular metabolism 
and that mutation of the critical tyrosine residue attenuates the virus in cell culture and, in case 
of RRV, also in mice. These results reveal that the hyperactivation of the PI3K–Akt–mTOR 
pathway by SFV and RRV, mediated by the interaction of nsP3 and p85, contributes to virus 
pathogenicity. 
Taken together, the data from papers I, II and III highlight and characterize three mechanisms 
by which Old World alphaviruses subvert cells – interactions with the SG nucleating protein 
G3BP, P-bodies and the PI3K–Akt–mTOR pathway, respectively. These viral subversion 
mechanisms are largely independent of each other and represent three different modes by which 
Old World alphaviruses ensure efficient virus growth. 
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1 INTRODUCTION 
1.1 STUDYING VIRUSES IS IMPORTANT AND NECESSARY 
Viruses are important pathogens for all other life forms – humans, animals, plants, bacteria and 
archaea. The word “virus” is derived from the Latin “vīrus”, which refers to poison or noxious 
liquids. Virus infection in humans can lead to a life-threatening impact on all organs including 
nervous system, lung, liver and intestines. Many devastating human diseases are caused by 
viruses, such as rabies, smallpox, influenza and acquired immune deficiency syndrome 
(AIDS). Disease-causing viruses are usually highly contagious and may lead to an epidemic or 
even a pandemic. Recent important outbreaks of virus diseases include severe acute respiratory 
syndrome (SARS) 2002–2003 (Tam 2004), influenza 2009–2010 (Poland 2010), consistently 
reported Marburg virus disease and Ebola, and Zika virus related microcephaly 2015–2017 
(Brady et al. 2019). In addition, some viruses are a constant threat for human health, including 
human immunodeficiency virus (HIV), human papilloma virus (HPV) and hepatitis viruses 
(HAV, HBV, HCV). Lastly, some viruses, such as chikungunya virus (CHIKV), are re-
emerging and expanding their circulation regions (Staples et al. 2009, Nasci 2014), which 
poses threat to human health as well. Virus infections in animals or plants can also have a 
highly destructive impact on society. Outbreaks of virus diseases in domestic animals, such as 
avian influenza in poultry and foot-and-mouth disease in cattle, cause huge economic losses. 
Infected animals and those at risk of infection are usually culled to prevent spread of the 
disease. Similarly, virus infections in plants, for example in potatoes and tomatoes, can 
dramatically decrease the production of the crops, which not only reduces the profits of farmers 
but also threatens food supply. Overall, viruses are adding heavy burdens to human health and 
society. 
Viruses are not only health-threatening, but also extremely abundant. They are the simplest and 
smallest forms of life on Earth. The virus particles, termed virions, just consist of a nucleic acid 
genome and a protein coat, and the size of virions varies from 20 to 500 nanometers. According 
to some estimation, the total mass of only bacterial viruses (bacteriophages) is more than 1000 
times that of all elephants on Earth. It is estimated that there are more than 1031 bacteriophages 
in the oceans on Earth. If lined up in a row, all the viruses would extend as far as 200 million 
light-years (Acheson 2011). The enormous abundance of viruses makes it difficult to eliminate 
or prevent virus diseases. Importantly, some viruses can also spread across different host 
species, e.g. from animal species to humans, which contributes to the increasing frequency of 
zoonoses in recent years, such as SARS, Ebola and H5N1 influenza. Viruses are transmitted 
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by a wide variety of routes, e.g. via aerosols, blood or contaminated surfaces. Some viruses are 
transmitted by vectors, for instance arthropods (arboviruses). 
Replication of viruses is entirely dependent on living cells since they lack basic elements for 
growth and replication, such as synthesis of molecular building blocks (nucleotides, amino 
acids, carbohydrates, lipids). Their extreme simplicity hence makes viruses obligatory 
intracellular parasites. During infection, viruses explore and reprogram intracellular pathways. 
This is a challenge to develop antiviral drugs, but also makes viruses unique tools for the study 
of cell biology. Some important discoveries were revealed from the study of viruses, such as 
the identification of eukaryotic RNA promoters, the internal ribosome entry site (IRES), RNA 
splicing and the isolation of numerous cellular oncogenes (Flint et al. 2015). In addition, some 
scientific subjects are derived from the study of viruses. For example, bacteriophage studies 
built the foundation of modern molecular biology and crystallization of tobacco mosaic virus 
pioneered structural biology. Virus studies have also enabled many applications of virus 
vectors. In combination with recombinant DNA techniques, virus vectors, such as Semliki 
Forest virus (SFV), are commonly used for gene delivery and expression in various cells and 
organisms. Gene therapy based on viral vectors, such as adenovirus or alphavirus, is an 
emerging area, with over 300 gene therapy projects in clinical trials worldwide (Lundstrom 
2018). Knowledge for development of antiviral therapies and application of viruses as study 
tools or vectors: This all derives from virus–host studies, highlighting the significance of such 
studies. 
1.2 ALPHAVIRUSES  
1.2.1  Alphaviruses and challenges for public health 
Alphaviruses are a group of viruses that are transmitted by mosquitoes between vertebrate hosts 
around the world. Infection in mosquitoes usually leads to life-long persistence, making 
mosquitoes the main reservoir and vectors for viral transmission. Transmission between 
species, including transmission to human beings, is often mediated through bites from infected 
blood-sucking mosquitoes. Alphaviruses belong to the virus family Togaviridae, which 
comprises two genera, Alphavirus and Rubivirus. “Toga” means “cloak” in Latin, which 
describes the appearance of the virus envelope. There are 27 members of the genus Alphavirus 
while there is only one member of the genus Rubivirus, rubella virus. Alphaviruses are 
commonly grouped into Old World alphaviruses and New World alphaviruses based on their 
original isolation sites and geographic distribution. Old World alphaviruses comprise important 
human pathogens, such as chikungunya virus (CHIKV), Ross River virus (RRV) and O’nyong-
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nyong virus (ONNV). New World alphaviruses mainly infect horses and rodents, but can infect 
humans as well, including Eastern equine encephalitis virus (EEEV), Venezuelan equine 
encephalitis virus (VEEV) and Western equine encephalitis virus (WEEV). Symptoms vary 
after infection with different alphaviruses. Infection with Old World alphaviruses rarely results 
in fatal disease, but leads to high morbidity in humans, characterized by high fever, rash and 
debilitating joint pain (Lwande et al. 2015), which can last for months or even years (Strauss 
et al. 1994). Infection with New World alphaviruses usually causes serious encephalitis, but 
with low morbidity in humans.  
Alphaviruses pose a significant threat to human health. Increasing outbreaks and spread of 
CHIKV have been recently reported. Since its first isolation in 1952, CHIKV circulated in 
African and Asian regions along the Indian Ocean for nearly three decades from the 1960s to 
the 1980s (Nasci 2014). After a short time of silence, an endemic of CHIKV began in Kenya 
2004 and spread to several Indian Ocean islands with over one thousand reported cases (Higgs 
2006). During 2005–2006, an outbreak of CHIKV occurred in India with over one million 
victims (Staples et al. 2009). Later, in 2007, the first autochthonous outbreak in Europe was 
reported in Italy with over two hundred cases (Liumbruno et al. 2008). Recently, locally 
acquired cases of CHIKV infection were also reported in Caribbean islands in 2013 and then 
the mainland of the USA in 2014 (Morrison 2014, McSweegan et al. 2015). Since the first 
reported case in Florida in 2014, CHIKV infections have been found in most states of the USA 
and became a nationally notifiable condition in 2015. Since then, infected cases have been 
reported each year including locally acquired cases (Centers for Disease Control and 
Prevention 2019, January 8). Due to its recent outbreaks and extended spread in the twenty-
first century, CHIKV is considered to be a re-emerging virus (Lwande et al. 2015). Millions of 
cases of CHIKV infection have been reported since its re-emergence (Weaver et al. 2015). 
The primary mosquito vector of CHIKV is Aedes aegypti. However, studies show that the 
related mosquito species Aedes albopictus was responsible for the CHIKV epidemic during 
2005–2006 on La Réunion island (Reiter et al. 2006). The vector change is attributed to the 
emergence of a mutation at position 226, alanine to valine, in the E1 envelope glycoprotein 
(E1-A226V), which enhanced virus infectivity in Ae. albopictus, with only marginal effect on 
its infectivity in Ae. aegypti (Tsetsarkin et al. 2007). It is surprising how fast the virus can adapt 
itself to a new vector species, since the mutation E1-A226V was not present in the isolates 
from the beginning of the outbreak but was dominant in the subsequent isolates (Schuffenecker 
et al. 2006). Compared to Ae. aegypti, Ae. albopictus is more abundant, leading to the long-
lasting and large-scale circulation of the outbreaks. The species Ae. albopictus is also widely 
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distributed in urban areas of Europe and the USA (Gratz 2004), which is considered to 
contribute to the expansion of CHIKV into the Western hemisphere.  
Sporadic outbreaks of other Old World alphaviruses have been consistently reported. ONNV 
was originally isolated in Northern Uganda in 1959 and re-emerged in 1996 in Southern 
Uganda. In 2014, high rates of ONNV and CHIKV transmission were reported in Coastal 
Kenya, indicating constant and re-emerged circulation of both alphaviruses (LaBeaud et al. 
2015). RRV is endemic in Australia and Papua New Guinea. In Australia, RRV infection is the 
most common arboviral infection, with approximately 5000 cases reported every year (Harley 
et al. 2001). Similar to RRV, another Old World alphavirus, Barmah Forest virus (BFV), is 
also endemic in Australia, causing notifiable infection (Suhrbier et al. 2012).  
The increasing challenge of alphaviruses for human health has brought more attention to 
research on this virus group. Semliki Forest virus (SFV) and Sindbis virus (SINV), mostly 
considered as avirulent for humans, are generally studied as laboratory models and are the best-
studied viruses in this field (Strauss et al. 1994). As model viruses, both SFV and SINV are 
able to establish infection in a variety of invertebrate and vertebrate cell lines, bringing many 
options for studies of these viruses. Recombinant infectious clones of several alphaviruses, 
including SFV and SINV, have been developed, making it easier to create viral mutants and to 
study the functions of individual viral components (Liljeström and Garoff. 1991a). With the 
help of infectious clones, many aspects of alphavirus biology have been revealed, regarding 
processes like viral protein translation and polyprotein processing, RNA replication, virion 
assembly and virus–host interaction. Generally, cellular processes are modified after alphavirus 
infection. Therefore, interaction studies of alphaviruses and host cells add new knowledge not 
only about the viruses but also about cellular processes. Even though most knowledge has been 
obtained based on SFV or SINV, the processes are largely conserved for other alphaviruses. 
However, one should be aware that the knowledge from the models is not always transferable 
to other viruses. This thesis will focus on the study of SFV and the extension of our findings to 
CHIKV and RRV. 
1.2.2 The alphavirus virion 
Alphaviruses are enveloped viruses with a positive-sense, single-stranded RNA genome. The 
envelope is an icosahedral lattice, consisting of the viral proteins E1 and E2 embedded in a 
host-derived lipid bilayer (Strauss et al. 2002). Both E1 and E2 are glycoproteins and have a 
transmembrane helix structure. They form heterodimers with a 1:1 ratio, and a spike complex 
is assembled with 3 copies of E1-E2 heterodimers, with 80 spikes (240 copies of E1-E2) in 
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total presented on the envelope surface (Helenius 1995). The envelope of some alphaviruses 
also contains small amounts of another viral protein, 6K (60 amino acid residues in SFV), 
which is considered to be an important component for the structure of the viral particle 
(Gaedigk-Nitschko et al. 1990, Lusa et al. 1991). Beneath the envelope lies an icosahedral 
protein shell made of 240 monomers of capsid protein (CP). Through its carboxyl terminus, 
CP interacts with the cytoplasmic domain of E2 in a perfect 1:1 symmetry match. This 
interaction is responsible for anchoring the spikes (outer layer of glycoproteins) to the structural 
capsid (Lee et al. 1996, Skoging et al. 1996). The amino terminus of CP is linked with viral 
genomic RNA (gRNA), assembled as nucleocapsid (NC), with viral gRNA folded inside the 
capsid shell. The gRNA of alphaviruses (42S RNA) contains two open reading frames (ORFs), 
with an approximate length of 11.7 kb. The first ORF in the 5ʹ part covers two thirds of the 
genome and encodes a nonstructural polyprotein (nsP), which gets processed into 4 
nonstructural proteins (nsP1–nsP4). The incoming full-length viral genome is directly used for 
the translation of the nonstructural polyprotein (discussed below). The second ORF, located in 
the 3ʹ part of the genome, is under the control of a subgenomic promoter. During infection, a 
shorter 26S subgenomic RNA (sgRNA), containing the second ORF and is transcribed and is 
used for the translation of the structural proteins. In addition to the two ORFs, other conserved 
sequences and structure elements are present in the viral RNA genome (reviewed in (Strauss 
et al. 1994, Jose et al. 2009)). For example, efficient transcription of sgRNA requires the 
presence of a conserved sequence element identified at the junction between the two ORFs 
(Pushko et al. 1997). 
1.2.3 Infection cycle of alphaviruses 
Infection of all viruses starts with the attachment of viral particles to susceptible cells. In case 
of alphaviruses, E2 is the viral attachment protein that binds to cellular receptors, which are 
probably different for the various alphaviruses (Smith and Tignor. 1980, Ludwig et al. 1996). 
So far, no specific cellular receptor has been identified for SFV. Virus tropism is attributed to 
species-specific receptors. Many viruses use more than one factor as receptor. However, it is 
still unknown why alphaviruses are able to establish infection in such a broad spectrum of 
vertebrate and invertebrate species. Two possible explanations for the phenomenon have been 
suggested: either a conserved cell receptor exists in different species; or viruses can alter the 
components of different cells to make use of them for attachment (Jose et al. 2009). Virions 
successfully attached to cellular receptors are transported into cells through clathrin-mediated 
endocytosis, which leads to the formation of clathrin-coated vesicles (Marsh et al. 1983, 
DeTulleo and Kirchhausen. 1998). Then, these vesicles lose the clathrin coats quickly and fuse 
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with early endosomes located near the cell surface. Early endosomes then mature to late 
endosomes during their transport from the cell surface to the perinuclear area. The main change 
during maturation is that late endosomes are more acidic than the early ones. The low pH 
environment destabilizes the E1-E2 heterodimers and causes a conformational re-arrangement 
of the complex, resulting in the fusion of the viral envelope with the endosome membrane. The 
fusion is triggered by the exposure of a fusion peptide in E1 (Glomb-Reinmund et al. 1998, 
Gibbons et al. 2000). The viral envelope around the NC is peeled off via membrane fusion, and 
the NC is released into the cell cytoplasm. Once the NC is exposed to the cytoplasm, cellular 
ribosomes are recruited through interaction with CP, followed by the release of the gRNA into 
the cytoplasm (Singh and Helenius. 1992). With ribosomes around, viral gRNA is immediately 
translated into the non-structural proteins.  
The non-structural proteins are translated as a polyprotein. For most alphaviruses, including 
SINV and CHIKV, the polyprotein nsP123 is dominantly translated, together with a smaller 
proportion of nsP1234 (10–20%). This variation is attributed to a leaky opal termination codon 
identified at the end of nsP3. For SFV (depicted in Fig. 1), only nsP1234 is translated due to 
the replacement of this stop codon with an arginine codon (CGA) (Firth et al. 2011). Translated 
nsP1234 is first cleaved in cis by nsP2 to produce nsP123 and nsP4. The complex formed by 
nsP123 and nsP4 facilitates the synthesis of (−)RNA genome (complimentary strand RNA 
genome). Subsequently, nsP123 is cleaved into nsP1 plus nsP23. A different complex is then 
formed by nsP1, nsP23 and nsP4, which is capable of synthesizing both (−)RNA and (+)RNA 
genomes. This complex, however, only exists shortly, because cleavage between nsP2 and 
nsP3 happens rapidly after the release of nsP1, resulting in fully cleaved nsPs. Individual nsPs 
then form a replicase variant that is only used for the synthesis of (+)RNA genome and sgRNA, 
leading to the cessation of (−)RNA genome synthesis (Strauss et al. 1994). All types of the 
replicases are present in viral replication complexes (RCs), where the viral RNA genome is 
replicated (Friedman et al. 1972). RCs are first assembled at the plasma membrane as clusters 
of membrane invaginations termed spherules. Later, spherules may also be present in the 
cytoplasm on the cytoplasmic surface of modified endosomes/lysosomes, termed cytopathic 
vacuoles of type I (CPV-I) (Grimley et al. 1968, Froshauer et al. 1988). During SFV infection, 
the spherules are internalized from the plasma membranes into the cytoplasm, which is 
dependent on the phosphatidylinositol-3-kinase (PI3K)–Akt–mammalian target of rapamycin 
(mTOR) signaling pathway, the actin cytoskeleton and the microtubule network. Inhibition of 
PI3K blocks the internalization of spherules, leading to the loss of CPV-I. These results indicate 
that CPV-I consist of internalized spherules and modified endosomes/lysosomes (Spuul et al. 
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2010). However, in other alphaviruses, such as CHIKV, RC internalization does not occur 
efficiently (Thaa et al. 2015). 
 
 
While replication continues, viral 26S sgRNA is produced under a sub-genomic promoter and 
then used as template for the translation of the viral structural proteins. Similar to viral nsPs, 
viral structural proteins are initially translated as a polyprotein and processed into individual 
proteins, including CP, p62 (named for SFV, as precursor E2 for other alphaviruses, pE2), 6K 
and E1. During translation of the structural proteins, CP is first released by autoproteolysis 
(Choi et al. 1991). Through the interaction between CP and the viral (+)RNA genome, NC is 
assembled in a multistep process in the cytoplasm and then transported to the plasma 
membrane. After the release of CP, the remaining polyprotein is translocated to the 
endoplasmic reticulum (ER), where further cleavages of the polyprotein into the individual 
structural proteins are carried out (Strauss et al. 1994). For polyprotein translocation, two signal 
Fig 1: Schematic sketch of SFV genome and replication. Once released into a host cell, the incoming 
positive-sensed, single-stranded RNA genome, ((+) genomic RNA in grey), is directly used as template for 
translation of nsP1–4. Different viral replicases are produced through polyprotein processing. Replicase 
nsP123 + nsP4 generates minus complementary viral genome ((−)complement RNA); Replicase nsP1 + nsP23 
+ nsP4 can replicate both plus and minus genomic RNA; Replicase consists of fully processed nsPs mainly 
replicates (+) genomic RNA and transcribes the (+) subgenomic RNA, which is used as the template for the 
translation of structural proteins. Adapted from (sonon 2009). 
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peptides have been shown to be involved, situated in the p62 and 6K (Liljeström and Garoff. 
1991b). Once separated in the ER, p62 and E1 interact to form heterodimers with the help of 
6K (Lusa et al. 1991). The p62-E1 heterodimers are then transported to the Golgi apparatus. 
The environment of the Golgi is acidic, thus could trigger the destabilization of p62-E1 
heterodimers. This is prevented by the pH-resistance of immature p62-E1 heterodimers. 
However, before they leave the Golgi, p62-E1 complexes are cleaved by the host cell protease 
furin to become mature E2-E1 heterodimers with the release of a third glycoprotein E3 from 
p62. E3 has been suggested to protect E2-E1 from premature activation after furin cleavage 
(Sjöberg et al. 2011), and remains in virion for SFV (Strauss et al. 1994). The E2-E1 
heterodimeric complexes are ultimately transported to the plasma membrane, where the 
complexes meet NCs for the assembly of new virions. Budding of newly formed virions at the 
plasma membrane is the last step of the viral lifecycle, during which the completion of the spike 
conformation is achieved (Garoff and Simons. 1974).  
1.2.4 Functions of the alphavirus non-structural proteins  
NsP1 (~60 kDa) of alphaviruses has two well-studied functions. During infection, nsP1 
catalyzes the capping reaction of newly synthesized viral gRNA and sgRNA and also functions 
to anchor viral RCs to membranes (Kääriäinen and Ahola. 2002). For newly synthesized viral 
RNA, the first step of the capping reaction is catalyzed by nsP2, with the removal of the 
gamma-phosphate from the first nucleotide at the 5ʹ end (Vasiljeva et al. 2000). Like eukaryotic 
capping enzymes, nsP1 possesses both methyltransferase and guanylyltransferase activity. 
Through its methyltransferase function, nsP1 first transfers a methyl group to GTP to form 7-
methyl-GTP, followed by the removal of di-phosphate from the GTP to form a covalent 
complex, nsP1-m7GMP, which is attributed to the guanylyltransferase activity of nsP1. The 
nsP1-m7GMP complex is then used for capping viral RNA. Nevertheless, the capping reaction 
of viral RNA is different to that of cellular mRNA, in which the GMP is first covalently bound 
before the methyl group is transferred. In addition, the cap structure of alphavirus mRNA 
contains only one methyl group on the first guanine base and is termed cap0 structure, which 
is different from the predominant cap structure of cellular mRNA containing one further methyl 
group (cap-1) on the ribose of the second nucleotide or two further methyl groups (cap-2), one 
each on the ribose of the following two nucleotides (Ahola et al. 1997, Kääriäinen and Ahola. 
2002). The membrane affinity of nsP1 is attributed to the direct binding of nsP1 to anionic 
membrane phospholipids as well as the palmitoylation of nsP1. The direct interaction is mainly 
mediated by a conserved polypeptide (residues 245–264) in nsP1; mutations in this polypeptide 
result in poor palmitoylation of nsP1 and are lethal to SFV (Ahola et al. 1999, Spuul et al. 
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2007). The palmitoylation is found on cysteine residues (residues 418–420) in SFV nsP1 
(Ahola et al. 2000).  
Alphavirus nsP2 (~90 kDa) is a multi-functional protein, distributed in both the cytoplasm and 
nucleus of the infected cells. In the cytoplasm, nsP2 mainly serves as RNA triphosphatase, 
RNA helicase and protease for the nonstructural polyprotein. As RNA triphosphatase, nsP2 
hydrolyses the gamma-phosphate of newly synthesized viral RNA, producing RNA substrates 
capped by nsP1 (Vasiljeva et al. 2000). NsP2 also acts as RNA helicase to unwind double-
stranded RNA structures to facilitate viral replication. This helicase activity requires the 
presence of NTPs and dNTPs (Gomez de Cedron et al. 1999). The putative NTP-binding site 
at the N-terminus of nsP2 is essential for both RNA triphosphatase and RNA helicase activities, 
since a single mutation (L192S) in this site ablates both activities. For SFV, this mutation 
abolishes replication completely (Rikkonen et al. 1994a, Rikkonen 1996). The protease activity 
of nsP2 is located at its C-terminus, which contains a papain-like cysteine protease domain 
(Vasiljeva et al. 2001). This domain is functionally active in both individual nsP2 and nsP2 
within nsP-polyprotein. Through its protease activity, nsP2 cleaves nonstructural polyproteins 
at different sites in the designated processing steps, leading to the formation of different 
replication complexes responsible for the regulation of viral RNA synthesis (Strauss et al. 
1994). Due to the presence of multiple nuclear localization signals (NLS), nsP2 is partly 
transported into the nucleus (Peränen et al. 1990, Rikkonen et al. 1994b). Mutations in NLS 
delay the nuclear transport of nsP2 and result in attenuated virus mutants. This attenuation has 
been explained by a failure of type I interferon inhibition and/or the deficiency of protein 
expression and RNA synthesis (Breakwell et al. 2007, Tamm et al. 2008). NsP2 is also highly 
related to virus replication and cytopathic effect. Several mutations in the region of nsP2 have 
been identified as key residues for efficient virus replication and establishment of persistent 
virus infection in vertebrate cells in SFV (Perri et al. 2000, Casales et al. 2008), CHIKV (Fros 
et al. 2013, Utt et al. 2015) and SINV (Gorchakov et al. 2005, Garmashova et al. 2006, 
Akhrymuk et al. 2018). Recent studies have shown that persistence infection of SINV or 
CHIKV in vertebrate host usually requires extra mutations in nsP1 and/or nsP3 in addition to 
those in nsP2 (Utt et al. 2015, Akhrymuk et al. 2018). In addition, studies of SINV suggest that 
nsP2 manipulates infection-induced shutoff of host transcription and translation (Gorchakov et 
al. 2005). The proposed mechanism is that nsP2 induces rapid degradation of Rpb1 (the 
catalytic subunit of RNA polymerase II) through a ubiquitin-dependent pathway (Akhrymuk 
et al. 2012).  
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Alphavirus nsP3 (~60 kDa) is less well studied compared to the other nsPs, but has been the 
focus of a lot of research recently (Götte et al. 2018). The protein has been suggested to play 
important roles as a scaffold that interacts with viral and host factors. Many nsP3-interacting 
partners have been identified by immunoprecipitation studies in SINV-infected cells (Cristea 
et al. 2006). The discovered binding partners could also be shared by other alphaviruses. 
However, further studies are needed to reveal the functions and mechanisms of the interactions. 
In addition, a recent study has developed a new microscopy approach to live-track CHIKV 
nsP3 based on the SNAP-tag self-labelling systemin in human cells, which can provide a 
sensitive and versatile platform for fundamental research in nsP3 functions (Remenyi et al. 
2017). All these studies will shed more light on the roles of alphavirus nsP3.  
NsP3 consists of three domains: the macro domain at the N-terminus, the alpha domain in the 
middle and the hypervariable domain (HVD) at the C-terminus (depicted in Figure 2, nsP3SFV). 
The first two domains are conserved in alphaviruses. The macro domain, spanning 
approximately 160–170 amino acids (aa), is evolutionarily conserved and also present in other 
viruses, e.g. rubella virus, some coronaviruses and hepatitis E virus, and also in some bacteria, 
archaea and eukaryotes ( Kääriäinen and Ahola. 2002). Two main features have been studied 
for viral macro domain, binding and hydrolysis of monomeric and polymeric ADP-ribose 
(MAR and PAR, respectively). The binding of MAR by nsP3 is seen in the macro domain of 
CHIKV and VEEV, but not SFV, while the binding of PAR is observed for all three 
alphaviruses (Malet et al. 2009, Neuvonen et al. 2009). Viral macro domains, such as in nsP3 
of CHIKV, SINV, ONNV and VEEV, are also known to be able to remove either ADP or PAR 
from substrates via hydrolysis. The catalytic efficiency of PAR hydrolysis is lower in CHIKV, 
SINV and ONNV than in VEEV (Li et al. 2016, Eckei et al. 2017). Recent studies of the macro 
domain in CHIKV nsP3 revealed that viral mutants are attenuated in either cell culture or a 
mouse model when the macro domain’s ability to bind or hydrolyze ADP is abolished 
(McPherson et al. 2017, Abraham et al. 2018). Interestingly, ADP-ribosylation of cellular 
proteins is found to be increased with CHIKV infection, which seems to be beneficial for the 
virus growth (Abraham et al. 2018). Also, alterations in macro domain have been shown to 
contribute the establishment of persistent replication of virus replicons for SINV (deletion of 
24-29aa in nsP3) (Akhrymuk et al. 2018) or CHIKV (I175L in nsP3) (Utt et al. 2015). The 
persistent replication of CHIKV replicon (CHIKVRepRLuc-FL-5A-PG-IL) is achieved 
together with alterations in nsP1 (F391L) and nsP2 (insertion of 5aa between 647/648 and 
P718G) (Utt et al. 2015). With help of the SNAP-tag based microscopy method (Remenyi et 
al. 2017), stable CHIKV nsP3 granules are observed to be associated with the persistent 
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replication of CHIKVRepRLuc-FL-5A-PG-IL, which provides some hints for the pathogenic 
studies of long-lasting symptoms of CHIKV infection (Remenyi et al. 2018). 
 
 
Similarly to the macro domain, the alphavirus unique domain (AUD) also covers ~160 aa ( 
Kääriäinen and Ahola. 2002). The crystal structure of this domain has been studied as a part of 
the nsP2-nsP3 polyprotein, revealing a new binding site for zinc ions in the domain. Thus, it is 
also named zinc-binding domain. The AUD was proven to be essential for viral pathogenesis 
(Shin et al. 2012), and mutational studies correlated the domain to viral RNA synthesis and 
neurovirulence (De et al. 2003, Tuittila and Hinkkanen. 2003). Recently, a mutagenic study 
revealed that AUD of CHIKV nsP3 plays multiple roles in replication and transcription of virus 
genome (Gao et al. 2019). Some combined mutations on the outer surface of AUD can abolish 
virus replication in both mammalian and mosquito cells, including R243A/K245A, 
V260A/P261A or C262A/C264A. The replication of CHIKV mutant harboring mutations 
P247A/V248A was either abolished or dramatically attenuated, with clear loss of membrane 
localization of nsP3 complexes and selective and striking reduction in the transcription of 
CHIKV sgRNA and subsequent synthesis of structural proteins. The reduction of CHIKV 
sgRNA is partly attributed to the impaired RNA-binding affinity of AUD of CHIKV nsP3 
caused by the mutations P247A/V248A (Gao et al. 2019).  
The HVD of nsP3 is seen as an interaction hub for host factors, considering it is intrinsically 
unstructured and of low complexity (McInerney 2015). Deletions in the HVD attenuate the 
virulence of SFV (Vihinen et al. 2001, Galbraith et al. 2006). The HVD varies in length and 
sequence between different alphaviruses, but several common features have been studied in 
this domain as depicted in Fig. 2 (reviewed in (Götte et al. 2018)). The N-terminal end of the 
HVD contains a cluster of phosphorylatable threonine and serine residues and is termed the 
hyperphosphorylated/acidic region. A mass spectrometry study mapped the major 
Fig 2: Schematic sketch of SFV non-structural protein 3 (nsP3SFV). Selected features in nsP3 HVD were 
displayed with colors as indicated above. T: threonine. Adapted from (Götte et al. 2018). 
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phosphorylation sites of SFV nsP3 to about 50 residues at the N-terminal end of HVD, with 
T344 and T345 as the major phosphorylation sites (depicted in Fig. 2) (Vihinen and Saarinen. 
2000, Vihinen et al. 2001, Galbraith et al. 2006). Mutations in the phosphorylation sites showed 
little effect on viral replication (Foy et al. 2013), but the deletion of 50 aa (residues 319–368) 
from this region in SFV nsP3 resulted in a significant reduction in the activation of the PI3K–
Akt–mTOR pathway, an important proviral signaling pathway (discussed below) (Thaa et al. 
2015). SFV-induced activation of the PI3K–Akt–mTOR pathway is attributed to the YEPM 
(369–372) motif in the HVD region, which was revealed in this thesis (paper III). Downstream 
of the hyperphosphorylated/acidic region, a proline-rich region is shared in many alphaviruses. 
This proline-rich region, including a P[I/V][P/A]PPR motif (Fig. 2), was shown to be the 
interaction site for the host factors amphiphysin-1 and -2, an interaction that facilitates viral 
replication (Neuvonen et al. 2011). In the rest of the HVD, two conserved sequences, 
containing two FGDF motifs (depicted in Figure 1), were described (Varjak et al. 2010, Panas 
et al. 2015b). These motifs are binding sites for the cellular protein G3BP (Ras-GAP SH3 
domain binding protein). Many studies have reported the interaction between nsP3 and G3BP 
(Cristea et al. 2006, Frolova et al. 2006, Gorchakov et al. 2008) and it is the two FGDF motifs 
of nsP3 and the NTF2-like domain of G3BP that mediate the interaction (Panas et al. 2014, 
Panas et al. 2015b). The main function of G3BP is the nucleation of stress granules (SGs), 
which have been described as antiviral RNA/protein assemblies in cells. The FGDF-mediated 
interaction between nsP3 and G3BP sequesters G3BP and counteracts the SG response (Panas 
et al. 2012). In this thesis, the structural and functional relevance of the FGDF-mediated 
interaction of nsP3 with G3BP was studied in molecular detail (paper I). After the disassembly 
of SGs, G3BP remains in the viral RCs, indicating its requirement for viral replication beyond 
the inhibition of the SG response. Knockdown of G3BP results in pronounced inhibition of 
viral replication for SINV and complete inhibition for CHIKV (Kim et al. 2016). The precise 
roles of G3BP during viral replication are not fully understood, but G3BP has been suggested 
to facilitate the switch from viral translation to genome amplification by unknown mechanisms 
(Scholte et al. 2015). In addition, other host factors, such as CD2-associated protein (CD2AP) 
and SH3 domain-containing kinase-binding protein (SH3KBP1), are also interaction partners 
of SFV and CHIKV nsP3 HVD (Mutso et al. 2018). 
At the extreme C-terminus, a degradation signal was found in nsP3 of both SFV and SINV and 
was narrowed down to 6 –10 residues and 36 residues respectively (Varjak et al. 2010). This 
degradation signal is effective when nsP3 is individually expressed, while nsP123 is rather 
resistant to the degradation. When fused to some reporters, such as EGFP or luciferase, the 
degradation signal remains functionally effective as well. The biological relevance of the 
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degradation signal is undefined, but the degradation has been suggested to regulate the ratio of 
the nsPs (Varjak et al. 2010). 
NsP3 in Old World alphaviruses has also been suggested as a determinant for mosquito vectors. 
ONNV is the only alphavirus transmitted by Anopheles mosquitos, while most other Old World 
alphaviruses, such as CHIKV, are transmitted by Aedes. A screening study for vector 
dependence found that a chimeric CHIKV, expressing ONNV nsP3, gained the ability to 
replicate with a comparable rate as wildtype ONNV in Anopheles gambiae mosquitoes 
(Saxton-Shaw et al. 2013). 
NsP4 (~70 kDa) mainly serves as the RNA-dependent RNA polymerase (RdRp). The RdRp 
activity of nsP4, including acting as RNA polymerase and terminal adenylyl-transferase, was 
demonstrated for SINV by mutational studies and in vitro studies with purified nsP4 (Hahn et 
al. 1989, Tomar et al. 2006, Rubach et al. 2009). The activity of nsP4 is attributed to the C-
terminal part (~500 aa) of the protein, which shows sequence homology to other RdRps, 
containing a conserved GDD motif ( Kääriäinen and Ahola. 2002). NsP4 is less abundant than 
other nsPs in infected cells for two reasons: the presence of an opal stop codon between the 
genes for nsP3 and nsP4 in some of the viruses (not SFV) (Strauss et al. 1994); and the 
uncommon tyrosine as the first amino acid of the protein, which leads to rapid degradation of 
nsP4 through the N-end rule pathway (de Groot et al. 1991, Varshavsky 1996). For SINV nsP4, 
the N-terminal tyrosine is a destabilizing signal, but also necessary for the polymerase activity, 
since substitutions, except with aromatic residues or histidine, are lethal (Shirako and Strauss. 
1998). The N-terminus (~100 aa) of nsP4 is unique in alphaviruses. Mutational studies of SINV 
nsP4 suggest that the N-terminus of nsP4 mediates the interaction with other nsPs to form 
different RCs for viral RNA synthesis (Rupp et al. 2011). 
1.3 STRESS GRANULES AND VIRUS INFECTION 
Stress granules (SGs) are cytoplasmic, non-membranous aggregates of non-translated 
messenger ribonucleoprotein particles (mRNPs). SGs are induced by various environmental 
stresses, including heat shock, oxidative stress, viral infection and UV radiation (Anderson and 
Kedersha. 2009). Experimentally, sodium arsenite (SA) is frequently used for SG induction. 
The formation of SGs is seen as an important adaptation of cells exposed to environmental 
stress (Kedersha and Anderson. 2002). In response to such stress, mRNA is rapidly and 
selectively sequestered into SGs, leading to the rapid change of translation from housekeeping 
proteins to stress-related proteins in stressed cells. SGs are treated as sites of mRNA storage 
and triage, as they are disassembled with the release of mRNA when the stress is removed. 
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They are highly dynamic structures and keep rapid exchange of mRNPs with the cytoplasm, 
with some proteins shuttling in and out within seconds (Kedersha et al. 2005). The composition 
of SGs is variable, with over a hundred different identified components. The main components 
of SGs are translationally stalled mRNA, early translation initiation factors and some RNA 
binding proteins such as G3BP (discussed below), Caprin-1 and TIA1 (Anderson and 
Kedersha. 2006). These components and stalled 48S preinitiation complexes are commonly 
present in all types of SGs, while recruitment of some specific factors to SGs varies with 
different stress stimuli. For example, Hsp27 was found in SGs induced by heat shock but not 
SGs induced by arsenite (Kedersha et al. 1999). In addition, several signaling molecules were 
reported to be present in SGs, suggesting SGs as signaling hubs (Kedersha et al. 2013).  
SG assembly involves multiple steps and usually initiates with the accumulation of non-
translated mRNPs. It has been suggested that there is an equilibrium between non-translated 
mRNA and polysome-bound (translated) mRNA, and that SGs assemble as a result of an excess 
of non-translated mRNA in the cytoplasm (Kedersha et al. 2000). The suggestion is indicated 
from the modulation of SGs by some drugs. For example, cycloheximide treatment reduces the 
level of non-translated mRNA by stabilizing polysomes, and consequently, SG induction by 
sodium arsenite is prevented in the presence of cycloheximide. In contrast, puromycin, which 
causes premature termination of translation and releases mRNA from polysomes, promotes the 
assembly of SGs when cells are stressed with sodium arsenite due to the increase of non-
translated mRNA ( Kedersha and Anderson. 2002). Translation inhibition can lead to an excess 
of non-translated mRNPs and hence SG induction. One of the best-studied pathways for SG 
formation is initiated with the phosphorylation of eIF2α, a subunit of the eukaryotic translation 
initiation factor eIF2. Phosphorylation of eIF2α affects the formation of the 48S preinitiation 
complex and inhibits translation initiation, resulting in stalled preinitiation complexes and “run 
off” of ribosomes. Phosphorylation of eIF2α can be catalyzed by either of four kinases: PKR 
(double-stranded RNA-activated protein kinase), PERK (PKR-like endoplasmic reticulum 
kinase), GCN2 (general control nonderepressible 2 kinase) or HRI (heme-regulated kinase) 
(Dever 2002). Different stimuli activate different kinases that phosphorylate eIF2α. For 
example, heat shock activates GCN2; oxidative stress activates HRI; and double-stranded 
RNAs, generated during infection with some RNA viruses, activate PKR. In addition, other 
pathways have also been described for SG induction, independent of eIF2α phosphorylation 
(Panas et al. 2016). A group of compounds, such as pateamine A, induces SGs via inhibiting 
the RNA helicase eIF4A (Dang et al. 2006). Other compounds, such as hydrogen peroxide, can 
induce SGs by disrupting the formation of the cap-binding eIF4F complex (Emara et al. 2012). 
Stalled preinitiation complexes have been suggested as the core of SG assembly upon the 
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inhibition of translation initiation, followed by the recruitment of nucleators for condensation 
(Panas et al. 2016). RNA binding proteins are seen as nucleators of SGs. Some of them can 
nucleate SGs when overexpressed, even without environmental stress (Kedersha and 
Anderson. 2007). One common feature of the nucleators is that many of them possess low-
complexity and intrinsically disordered protein regions (IDPR) that have high conformational 
flexibility. These regions can mediate weak interactions, which facilitate the accumulation of 
IDPR-containing proteins and hence lead to a quick and transient segregation of the proteins 
into a subcellular compartment (Nott et al. 2015). In addition to conformational flexibility, 
IDPR proteins can also quickly achieve post-translational modifications, which usually leads 
to a fast change of their structural conformation and subsequent interactions. The fact that they 
contain IDPR regions enables SG nucleators to convey the highly dynamic processes of SG 
formation and maintenance (Panas et al. 2016). 
G3BP is one of the SG-nucleating proteins and an essential component for SG formation. The 
protein, with the full name “Ras GTPase-activating protein-binding protein”, was first 
described as a binding partner to the SH3 domain of the Ras GTPase-activating protein (GAP) 
(Parker et al. 1996). There are two isoforms, G3BP1 and G3BP2 (collectively referred to as 
G3BP), sharing 74% amino acid sequences similarity. Both G3BP1 and G3BP2 are 
ubiquitously expressed in most cells, as homodimers and/or heterodimers (Matsuki et al. 2013). 
Single knockdown of either G3BP1 or G3BP2 results in the increase in expression of the other, 
indicating a compensaroty relationship of the two isoforms (Matsuki et al. 2013). Only 
simultaneous knockdown of both G3BP1 and G3BP2 renders the cells unable to form stress 
granules upon eIF2α dependent and eIF2α independent stresses (Kedersha et al. 2016). G3BP 
consists of four domains: a nuclear transport factor 2 (NTF2) like domain, a proline-rich 
domain, an RNA-recognition motif (RRM) and an arginine-glycine-glycine (RGG) motif 
(Tourriere et al. 2003). The NTF2-like domain displays sequence homology to the cytoplasmic 
nuclear transport factor 2 (NTF2), which transports cargo into the nucleus (Clarkson et al. 
1996). However, G3BP does not function as a nuclear transport factor. Instead, the NTF2-like 
domain is a binding site for proteins containing FGDF motifs, including ubiquitin-specific 
protease 10 (USP10) and some viral proteins, such as alphavirus nsP3 and herpes simplex virus 
(HSV) protein ICP8 (Panas et al. 2015b). Interaction of G3BP with Caprin-1 or USP10 was 
shown to be involved in the assembly or disassembly of SGs (Kedersha et al. 2016). The viral 
proteins with FGDF motifs, in particular nsP3 of alphaviruses, mimic this disassembly 
principle of SG modulation (Panas et al. 2015b). The NTF2-like domain has also been 
suggested to contribute to dimerization of G3BP (Tourriere et al. 2001). The proline-rich 
domain is thought to bind to the SH3 domain of Ras GAP (Parker et al. 1996). The RRM motif 
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mediates the interaction of G3BP with nucleotides of RNA (Nagai et al. 1995, Kennedy et al. 
2001). The RGG domain of G3BP has been recently revealed as essential for SG competence 
and the interaction with 40S ribosome subunits (Kedersha et al. 2016). In a reconstituted cell 
line expressing only a truncated version of G3BP lacking the RGG domain, induction of SGs 
by sodium arsenite was blocked and interactions were abolished between G3BP and some 
factors of 40S ribosome subunits (Kedersha et al. 2016).  
SG assembly is important for cell adaptation in response to environmental stress, including 
viral infection. Most viruses have evolved different mechanisms to modulate and subvert SG 
assembly at some point during infection (reviewed in (Valiente-Echeverria et al. 2012, Lloyd 
2013, Reineke and LIoyd. 2013)). The viral modulation of the SG response can be categorized 
into 3 different types: (a) inhibition of SG induction, such as upon infection with some 
flaviviruses; (b) induction and maintenance of SGs during infection, such as upon vaccinia 
virus infection; and (c) induction of SGs at early stages of infection followed by disassembly 
later, e.g. upon poliovirus or alphavirus infection (White and LIoyd. 2012). Our previous work 
has revealed that alphaviruses antagonize SGs by sequestering the SG nucleating protein G3BP 
into RCs. This sequestration is mediated by the interaction between FGDF motifs of nsP3 and 
the NTF2-like domain of G3BP (Panas et al. 2012, Panas et al. 2014, Panas et al. 2015b). 
Sequestration of G3BP into viral RCs suppresses SG assembly. In addition, this interaction is 
essential for efficient viral replication, but the reasons for this have remained unclear (Panas et 
al. 2012, Kim et al. 2016, Schulte et al. 2016). One aim of this thesis is to further characterize 
this interaction and its functions. 
1.4 RNA PROCESSING BODIES AND VIRUS INFECTION 
RNA processing bodies (P-bodies or PBs) are discrete RNA granules consisting of 
translationally suppressed mRNPs. The main components enriched in P-bodies are translation-
repressed mRNA and factors involved in mRNA decay, such as decapping enzymes, 
deadenylases, exonucleases, and some RNA-binding proteins involved in nonsense-mediated 
decay or microRNA-mediated silencing (Decker and Parker. 2012, Lloyd 2013). Thus, P-
bodies are usually considered as degradation sites of mRNA (Arribere et al. 2011). 
Direct mRNA degradation is carried out by three ribonucleases (RNases): endonucleases that 
initiate cleavage within the body of mRNA, 5′ exonucleases that digest mRNA in 5′ – 3′ 
direction, and 3′ exonucleases that remove nucleotides from the 3′ end of mRNA (Houseley 
and Tollervey. 2009). Most mRNA molecules in eukaryotic cells carry a 5′ cap structure and 
3′ poly (A) tail, two features which ensure translation and also protect mRNA from digestion 
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by exonucleases. In order to degrade mRNA, the cap structure and/or the poly (A) tail need to 
be removed to give access to exonucleases. The majority of mRNA decay is initiated by 
deadenylation, the removal of the poly (A) tail at the 3′ end. In mammalian cells, the poly (A) 
tail of mRNA molecules is first shortened by Pan2 in association with Pan3 to about 110 
nucleotides, followed by the further shortening mediated by the Ccr4-NOT complex (Chen and 
Shyu. 2011). Deadenylation of mRNA is seen as the rate-limiting step and also a reversible 
process. Thus, deadenylation is treated as a critical checkpoint for mRNA before it is 
committed for decay (Chen and Shyu. 2013). Interestingly, recent studies implicate that 
uridylation at the 3′ end of mRNA may also serve as a trigger for mRNA degradation (Labno 
et al. 2016).  
After removal of the poly (A) tail, mRNA decay can be carried out either by exosomes from 3′ 
to 5′, or alternatively by the exonuclease XRN1, which requires the removal of the 5′ cap 
structure (decapping). The whole process of decapping is well regulated with mRNA 
decapping enzyme 2 (Dcp2), acting together with many decapping enhancers, such as Dcp1a, 
Hedls, the protein complex Lsm1–7, and the helicase DDX6 (Rck/p54) (Narayanan et al. 
2013). Notably, decapping is thought to be an irreversible event that targets the mRNA for 
degradation by XRN1 and hence serves as a backup pathway/checkpoint for mRNA decay via 
deadenylation (Chen and Shyu. 2013). The endonucleolytic degradation of mRNA can be 
mediated by the RNA-induced silencing complex (RISC). Other pathways targeting certain 
types of mRNA for degradation are triggered by deadenylation as well, including degradation 
of mRNA containing AU-rich elements (ARE), nonsense-containing RNA and microRNA-
targeting RNA (Chen and Shyu. 2013). 
Several studies provide experimental evidence that P-bodies are mRNA degradation sites: For 
example, stabilization of mRNA by cycloheximide protects mRNA from degradation and 
results in dispersion of P-bodies (Cougot et al. 2004), and P-bodies are dispersed when 
deadenylation is inhibited (Zheng et al. 2008). In contrast, there are other studies showing that 
the processes of mRNA degradation also proceed in the absence of P-bodies, including mRNA 
decay, nonsense-mediated mRNA decay and RNA-mediated gene silencing (Eulalio et al. 
2007, Stalder and Muhlemann. 2009).  
Both deadenylation and decapping are highly related to P-body dynamics. P-bodies are 
enriched with factors directly involved in these processes, such as the deadenylation factors 
Pan2, Pan3 and Ccr4 (Zheng et al. 2008) and the decapping factors Dcp1, Hedls and DDX6 
(Cougot et al. 2004). When deadenylation is impaired by knocking down Caf1, a catalytic 
enzyme in the Ccr4-NOT complex, or by expressing a dysfunctional Caf1, P-bodies are 
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dispersed, suggesting that their formation depends on mRNA deadenylation (Zheng et al. 
2008). Based on these results, a model for P-body formation driven by deadenylation has been 
suggested: when the poly (A) tail of mRNA is shortened by Pan2-Pan3 as the first step of 
deadenylation, mRNA is dissociated from the poly (A) binding protein complex, which enables 
the access of Ccr4-NOT for the second step of deadenylation. The first shortening step is 
reversible and seen as the start of P-body formation. At this stage, mRNA can either resume 
translation or proceed to further deadenylation and subsequent decapping, which depends on 
the recruitment of decapping factors. The complexes consisting of deadenylation and 
decapping factors are thought to be the core of P-bodies (Chen and Shyu. 2013). However, this 
model is challenged by a recent study, in which P-bodies were successfully purified via 
fluorescently labeled key P-body components, followed by transcriptomic profiling, which 
revealed that mRNA aggregated in P-bodies contains normal poly (A) tails and lacks any sign 
of degradation (Hubstenberger et al. 2017). Two other recent studies tracked the life cycle of 
tagged mRNAs in live cells and observed that mRNA degradation occurs diffusely in the 
cytoplasm rather than in P-bodies (Horvathova et al. 2017, Tutucci et al. 2018). All these results 
suggest P-bodies as storage sites of translationally repressed mRNPs.  
Results of decapping studies however suggest a kinetic model for P-body formation driven by 
an excess of translationally repressed mRNPs (Franks et al. 2008). This model is mainly based 
on the fact that many decapping factors possess dual functions as both translation suppressors 
and decapping activators. Observations in favor of this model include: Treatment of cells with 
cycloheximide reduces free mRNA in the cytoplasm and leads to a rapid dispersion of P-bodies 
(Cougot et al. 2004); in contrast, puromycin causes premature termination of translation and 
release of polysome-free mRNA, which contributes to P-body formation under stress (Eulalio 
et al. 2007); recent data show that interactions between DDX6 and 4E-transporter (4E-T) 
mediate translation suppression and are essential for P-body assembly (Ayache et al. 2015, 
Kamenska et al. 2016). This model also suggests that P-bodies serve as mRNA decay and 
storage sites, as translation-suppressed mRNA are not always committed for decay. 
Nevertheless, regarding the formation and dispersal of P-bodies, the signaling cascades and 
mechanisms are unknown and less well studied than those for SGs. In addition to deadenylation 
and decapping pathways, intact cellular transport networks are also important for the transport 
and dynamic changes of P-bodies (Aizer et al. 2008). 
P-bodies may have a dual role as mRNA decay and storage sites. Through live cell imaging, 
tagged mRNA was found to reside in P-bodies under stress conditions and to be gradually 
released from P-bodies to the cytoplasm when stress was removed (Aizer et al. 2014). Similar 
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to SGs, P-bodies respond to different stimuli and vary in number and size when translation 
arrest occurs. Furthermore, physical links between P-bodies and SGs have been shown by live 
cell imaging. Some proteins are found in both SGs and P-bodies (Kedersha et al. 2005). When 
overexpressing tristetraprolin, a shared component of SGs and P-bodies, these two types of 
cytoplasmic foci are transiently positioned in close proximity with each other, indicating direct 
communication between these two structures (Kedersha et al. 2005). Multiple connections 
between polysomes, SGs and P-bodies have been observed. This observation provides the 
experimental basis for the mRNA cycle model, which states that cytoplasmic mRNA can exist 
and be transported between the three structures (Balagopal and Parker. 2009).  
In summary, mRNA deadenylation and decapping are both connected to P-bodies, while the 
relative contribution of these processes to P-body formation and dynamics is rather unclear. P-
bodies may serve as mRNA decay and/or storage sites with potential links to SGs. 
Virus infections can manipulate P-bodies in different ways (reviewed in (Pattnaik and Dinh. 
2013, Poblete-Duran et al. 2016)). Currently, most viruses shown to alter P-bodies during 
infection are RNA viruses, of which the majority are positive-strand RNA viruses. In cells 
infected with hepatitis C virus (HCV) or West Nile virus (WNV), P-bodies are dispersed or 
reduced in number, with some P-body components hijacked or recruited to the virus replication 
sites (Ariumi et al. 2011, Chahar et al. 2013). During poliovirus infection, P-bodies are 
dispersed concomitantly with the accelerated degradation of some P-body scaffold proteins, 
including the decapping factors Dcp1a and XRN1 as well as the deadenylase complex 
component Pan3 (Dougherty et al. 2011). These results suggest that P-bodies are disassembled 
during poliovirus infection by inhibition of deadenylation (Dougherty et al. 2011), considering 
that deadenylation has been shown to be required for P-body formation (Zheng et al. 2008). 
Follow-up studies from the same group added that disassembly of P-bodies is mainly attributed 
to virus proteases, as individual expression of viral proteases, including 3CD, 2A(pro) and 
3C(pro), repressed or dispersed P-bodies (Dougherty et al. 2015). The negative-strand RNA 
virus influenza A virus also interferes with the formation of both SGs and P-bodies. Viral non-
structural protein 1 (NS1) interacts with RNA-associated protein 55 (RAP55, also known as 
LSM14A), a shared protein in both SGs and P-bodies. Overexpression of NS1 inhibits the 
assembly of both RNA granules (Mok et al. 2012). So far, little is known about the fate of P-
bodies during alphavirus infection, which is investigated in this thesis.  
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1.5 THE PI3K–AKT–MTOR PATHWAY AND VIRUS INFECTION 
The PI3K–Akt–mTOR pathway is one of the most important pathways responsible for cell 
survival in different environments, by regulating the transition between cell anabolism and 
catabolism. Many cellular processes, such as cell proliferation, cell division, apoptosis and cell 
metabolism, are controlled or affected by this pathway (reviewed in (Manning and Cantley. 
2007, Wong et al. 2010, Laplante and Sabatini. 2012)).  
The activation of the pathway typically starts with the binding of a growth factor such as insulin 
to its receptor at the plasma membrane, which induces dimerization of the receptor and 
phosphorylation of a tyrosine residue in the cytoplasmic tail of the receptor or an associated 
protein. Phosphorylated tyrosine in the sequence context YXXM leads to activation of PI3K, 
class IA. Class IA PI3Ks consist of a regulatory subunit p85 and a catalytic subunit p110, with 
p85 serving as a stabilizer and inhibitor of the p110 subunit. In mammalian cells, there are three 
isoforms of the p110 subunit (α, β, and δ) and two isoforms of the p85 regulatory subunit (α, 
β). Subunit p85 contains two Src homology 2 (SH2) domains, which interact with phospho-
tyrosine in YXXM motifs (Songyang et al. 1993). Through this interaction, active p110 is 
released and recruited to the plasma membrane, where it converts the plasma membrane lipid 
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) to phosphatidylinositol-3,4,5-trisphosphate 
(PI(3,4,5)P3). PI(3,4,5)P3 subsequently facilitates the phosphorylation and activation of the 
protein kinase Akt, by recruiting both Akt and its kinase phosphoinositide-dependent kinase 1 
(PDK1) into close proximity at the plasma membrane. Both proteins contain a pleckstrin-
homology domain for binding to PI(3,4,5)P3. Full activation of Akt requires phosphorylation 
of two amino acids: T308, phosphorylated by PDK1; and S473, the phosphorylation of which 
is primarily attributed to the mTOR–rictor complex (mTORC2) (Backer et al. 1992, Rordorf-
Nikolic et al. 1995, Yu et al. 1998). Full activation of Akt results in phosphorylation of many 
substrates related to cell metabolism and survival. The mechanistic target of rapamycin 
(mTOR) in the mTOR–raptor complex (mTORC1) is one of the main downstream substrates 
of Akt. Activation of mTORC1 promotes synthesis of proteins and lipids and keeps cells in a 
pro-survival state.  
Virus infection often interferes with the PI3K–Akt–mTOR pathway (reviewed in (Diehl and 
Schaal. 2013, Le Sage et al. 2016)). In regards to Old World alphaviruses, CHIKV activates 
the pathway to a moderate level but SFV hyperactivates the pathway, in which the 
hyperactivation of the pathway is demonstrated as strong, persistent activation, even sustained 
in starved cells, where the pathway is normally inactive (Thaa et al. 2015). The mechanistic 
basis of PI3K–Akt–mTOR hyperactivation in SFV is investigated in this thesis.  
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2 RESULTS 
2.1 RESULTS PAPER I 
Previous studies have revealed that the FGDF motif directly binds to the NTF2-like domain of 
G3BP and is necessary and essential for the interaction (Panas et al. 2014, Panas et al. 2015b). 
The motif is found in many cellular proteins and also in some viral proteins, such as alphavirus 
nsP3 (Panas et al. 2015b). There are duplicates of the FGDF motif, FGDFN and FGDFC, in 
alphavirus nsP3, including nsP3SFV and nsP3CHIKV, in contrast to a single copy of the motif in 
the cellular proteins. The crystal structure was previously studied for the NTF2-like domain of 
G3BP2 in complex with a short FGDF containing peptide LTFGDFDE, demonstrating that the 
peptide binds to the hydrophobic pocket of the NTF2-like domain (Kristensen 2015). The 
peptide used in that study however only corresponds to the FGDFN in SFV-nsP3 and may not 
reflect the full binding mode of the two FGDF motifs in nsP3 to the NTF2-like domain of 
G3BP. Thus, we investigated the structural and biological significance of the duplicate FGDF 
motifs in alphavirus nsP3. To answer these questions, we started with nsP3SFV studies. Through 
collaboration, the crystal structure was solved for the NTF2-like domain of G3BP1 (Fig. 3A, 
left-hand side) in complex with a peptide derived from nsP3SFV harboring both FGDFN and 
FGDFC motifs (residue 449  473, nsP3SFV-25, LTFGDFDEHEVDALASGITFGDFDD, see 
Fig. 3A, right-hand side). Considering that the NTF2-like domain of G3BP1 forms 
homodimers (G3BP1)2, our structure data show that each nsP3SFV-25 peptide can engage with 
two (G3BP1)2, leading to the formation of a poly-complex of (G3BP1)2 interconnected by 
nsP3SFV-25 (Fig. 3B). This structure suggests an oligomer-inducing function of alphavirus 
nsP3.  
To further characterize the two FGDF motifs, recombinant constructs were generated to 
express the 36 C-terminal residues (447–482) of nsP3SFV fused to the C-terminus of EGFP. 
These constructs either carry the natural sequence (EGFP-36-WT) or a mutation, Phe to Ala, 
in the FGDFN (EGFP-36-F3AN), FGDFC (EGFP-36-F3AC) or both motifs (EGFP-36-F3ANC). 
Using these constructs, we studied the interaction between the endogenous G3BP1 and the 
individual FGDF motifs in HEK293 cells after transfection with either of the constructs or the 
empty EGFP vector. Cells were lysed at 24 hours post transfection (hpt) and the lysates were 
subjected to immunoprecipitation with anti-GFP antibodies, followed by immunoblotting for 
GFP, G3BP1 and actin. EGFP-36-WT bound efficiently to G3BP1, while EGFP-36-F3ANC did 
not bind at a detectable level (Paper I, Fig. 4 (a)), which is consistent with our previous studies  
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(Panas et al. 2015b). The data for G3BP1 and the nsP3 mutants with single FGDF mutations 
revealed a weak interaction of G3BP1 with EGFP-36-F3AN but a very strong interaction with 
EGFP-36-F3AC (Paper I, Fig. 4 (a)). These different interaction intensities were confirmed with 
densitometric analysis of the G3BP1 bands. We also studied the effect of other regions in 
nsP3SFV on the interaction with G3BP1, by expressing either the HVD region (residues 319–
482) or the full length of nsP3 carrying the correspondent mutations in the same backbone 
vector as fusion proteins with EGFP. Highly similar results were observed regardless of the 
length of nsP3SFV truncation: WT version and single mutant F3AC always efficiently bound 
G3BP1, whereas the double mutant F3ANC did not bind to detectable levels and the single 
mutant F3AN bound much less G3BP1 than the corresponding nsP3-WT (Paper I, Fig. 4 (b) 
and (c)). The results of these studies in cells revealed a hierarchical binding mode for the 
Fig. 3: The two FGDF motifs in nsP3SFV-25 inter-connect (G3BP1)2 into a poly-[(G3BP1)2: nsP3SFV-25] 
complex. (A) A sketch of G3BP1 and nsP3SFV.The NTF2-like domain of G3BP1 and the nsP3-25 region in 
nsP3 used for crystal structure studies are highlighted. (B) The dimer of the NTF2-like domain of G3BP1and 
a single nsP3SFV-25 peptide molecule are displayed in yellow and green, respectively. The pink bar represents 
the twofold pseudo-symmetry axis between each G3BP1 subunit. While chain A of G3BP1 binds to the N-
terminal nsP3SFV-25 FGDF motif (FGDFN, highlighted in red) comprising Phe-451 to Phe-454, the chain B of 
G3BP1 binds to the C-terminal FGDF motif (FGDFC) comprising Phe-468 to Phe-471, thus creating a 
multimeric assembly of [(G3BP1)2: nsP3SFV-25] complexes. The [(G3BP1)2: nsP3SFV-25] complexes of two 
adjacent asymmetric units are displayed semi-transparent. The N- and C-termini of the NTF2-like domain of 
G3BP1 are highlighted as spheres.  
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duplicate FGDF motifs and suggest a higher binding affinity to G3BP1 for FGDFN than 
FGDFC.  
In addition, we also expressed and purified EGFP-nsP3SFV-36, analogous to EGFP-36 used for 
the studies in cells, in all variants (WT, F3AN, F3AC, F3ANC) to investigate the binding to 
G3BP1 in vitro. Through collaboration, the binding affinities were analyzed by microscale 
thermophoresis (MST) between the purified NTF2-like domain of G3BP1 and the EGFP-
nsP3SFV-36 proteins. The MST results show that FGDFN has higher binding affinity to the 
NTF2-like domain of G3BP1 than FGDFC (Paper I, Fig. 3 (b)), supporting the observations 
from our studies in cells. 
The next question was whether the FGDF motifs of SFV nsP3 behave similarly in the context 
of infection. To address this question, the respective mutations were introduced into the SFV 
genome (as depicted in Fig. 4A) and correspondent recombinant viruses, i.e. SFV-F3AN, SFV-
F3AC and SFV-F3ANC, were rescued from infectious clones. The interaction between nsP3 and 
G3BP1 was studied after infection of baby hamster kidney (BHK) cells with SFV-WT or the 
FGDF-mutated recombinant viruses. Cells were lysed at 8 hours post infection (hpi) and 
subjected to immunoprecipitation with nsP3 antiserum. Subsequent immunoblotting showed 
that WT nsP3 efficiently interacted with G3BP1 and that F3AC nsP3SFV, with the intact FGDFN 
motif, bound nearly half (49.5 ± 2.0%) of G3BP1 in comparison to WT nsP3, according to 
densitometric analysis of the G3BP1 bands (Fig. 4B). The other two nsP3 mutants, F3AN 
nsP3SFV and F3ANC nsP3SFV did not bind G3BP1 at any detectable level, as shown in the 
densitometry results (Fig. 4B). The results from virus infection studies support the model that 
two FGDF motifs bind two G3BP1 dimers and a single FGDF motif binds one G3BP dimer, 
with the binding of FGDFC happening only when FGDFN binds first. 
G3BP1 is recruited to viral replication complexes (RCs) during SFV infection, which is 
dependent on its interaction with FGDF motifs in nsP3 (Panas et al. 2012). Recruitment of 
G3BP1 to RCs was tested by immunofluorescence in BHK cells after infection with the same 
panel of viruses as used for the immunoprecipitation studies displayed in Fig 4B. Infected cells 
were fixed at 8hpi and probed for nsP3 and G3BP. The results show that robust G3BP1 signals 
accumulated with WT nsP3SFV, indicating efficient recruitment of G3BP1, while the 
colocalization of G3BP1 was intermediate with F3AC nsP3SFV and only seen with a small 
proportion of F3AN nsP3SFV and very weak with F3ANC nsP3SFV (Fig. 4C).  
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Previous studies demonstrated that SFV-F3ANC, in which  both FGDF motifs are mutated, is 
attenuated (Panas et al. 2015b). We further studied how virus growth was affected with single 
mutations in the motifs. Multiple and single step growth curves were determined in BHK cells 
Fig. 4: Both FGDF motifs are necessary for efficient SFV replication. (A) FGDF motifs in nsP3 of SFV 
and mutations thereof. (B) BHK cells were mock-infected or infected at MOI 10 with SFV WT, -F3AN, -F3AC 
or -F3ANC. At 8 hours post infection (hpi), cell lysates were prepared and subjected to immunoprecipitation 
with nsP3 antiserum and separated by SDS–PAGE. Lysates and IPs were probed for nsP3, G3BP1 or actin. 
Representative result. HC, immunoglobulin heavy chain. Lower panel, densitometry of the intensities of 
G3BP1 bands in IPs as displayed in the upper panel and displayed relative to SFV WT. Data are averages from 
two experiments, and error bars are standard deviations. (C). Cells infected as in (B) were fixed at 8 hpi and 
stained for nsP3 (green) and G3BP1 (red). Nuclei in blue. Scale bar 10 µm. (D). BHK cells were infected with 
the indicated viruses at an MOI of 0.1. At 4, 8, 12, 24 and 36 hpi, supernatants were collected and SFV titers 
were quantified by plaque assay in BHK cells. Data are means of two to four independent experiments. Error 
bars indicate standard error of the mean (SEM). 
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after infection with SFV-WT, SFV-F3AN, SFV-F3AC or SFV-F3ANC at low (0.1) and high (10) 
multiplicity of infection (MOI), respectively. Released viruses were collected at the indicated 
time points and titrated in BHK cells by plaque assay. Growth curves at both low (Fig. 4D) and 
high MOI (Paper I, Fig. 5 (c)) show that all three virus mutants were able to grow, but 
significantly slower than WT virus after 8hpi, and also produced much less progeny than WT 
virus. Overall, the results from infection studies demonstrate that only duplicate FGDF motifs 
promote efficient virus growth, which is likely attributed to the efficient interaction with G3BP 
and subsequent sequestration of the protein to viral replication complexes. 
The duplicate FGDF motifs are also conserved in nsP3 of CHIKV (nsP3CHIKV) (Varjak et al. 
2010), mediating the interaction with G3BP (Panas et al. 2014). We asked whether the 
knowledge gained from SFV was transferable to the more important human pathogen CHIKV. 
Based on the sequence homology, a structural model was built for the NTF2-like domain of 
G3BP1 in complex with a similar peptide nsP3CHIKV-23 derived from nsP3CHIKV via secondary 
structure predictions (Paper I, Fig. 6). The model predicts that nsP3CHIKV-23 binds two G3BP1 
molecules in a similar way as demonstrated with nsP3SFV-25 (Paper I, Fig. 6). However, the 
peptide sequence for formation of an alpha helix between the two FGDF motifs are three amino 
acids longer in nsP3CHIKV than in nsP3SFV, which results in an elongated helix and a shift of the 
FGDFC motif in nsP3CHIKV (Fig. 5A). This shift of FGDFC is predicted to cause a less stable 
interaction with G3BP1, likely due to the exposure of the hydrophobic face of the helix that is 
covered by G3BP1 in the case of nsP3SFV (Paper I, Fig. 6). The significance of the individual 
FGDF motifs in nsP3CHIKV regarding binding to G3BP1 was assessed in experiments analogous 
to those conducted for SFV. Full length nsP3CHIKV was expressed as EGFP fusion protein in 
HEK293 cells with WT motifs (nsP3CHIKV-WT), mutations in either of the duplicate FGDF 
motifs (F479A, nsP3CHIKV-F3AN or F497A, nsP3CHIKV-F3AC) or in both motifs (nsP3CHIKV-
F3ANC). At 24hpt, cells were lysed and subjected to anti-GFP immunoprecipitation. 
Immunoblotting results for GFP, nsP3CHIKV and actin revealed a similar hierarchical binding 
mode of nsP3CHIKV to G3BP1, with strong and efficient G3BP1 binding to nsP3CHIKV-WT or 
nsP3CHIKV-F3AC, while the binding to nsP3CHIKV-F3AN or nsP3CHIKV-F3ANC was much weaker 
or non-noticeable, which mirrors the results for nsP3SFV (Fig. 5B). The single mutations were 
then introduced to the CHIKV genome to evaluate the contribution of the individual FGDF 
motifs to G3BP1 binding in the context of virus infection. During our attempts to rescue the 
recombinant CHIKV mutants, CHIKV-F3AN, CHIKV-F3AC or CHIKV-F3ANC after 
transfection of BHK cells, we noticed huge delays for the development of cytopathic effect, 
which appeared at 60hpt for CHIKV-F3AN and CHIKV-F3AC and 84hpt for CHIKV-F3ANC 
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Fig. 5: Both FGDF motifs are necessary for efficient CHIKV replication. (A) Upper panel: The sequence 
alignment of the FGDF motif containing residues from nsP3SFV (Uniprot ID P08411) and nsP3CHIKV (Q5XXP4) 
highlights the two conserved N- and C-terminal (L/I)TFGDFD motifs. Residue numbers indicate nsP3SFV. A 
helical spacer region (highlighted in red) was predicted for both FGDF motif containing residues of nsP3SFV 
and nsP3CHIKV, as revealed in the nsP3-25SFV crystal structure. Lower panel: Structural modelling of the 
FGDF-motif-containing peptide sequence of nsP3CHIKV (red) suggests a longer helical region than that of 
nsP3SFV (green), with a rotated and shifted FGDFC motif. (B) HEK293 cells were mock-transfected or 
transfected with pEGFP, pEGFP-nsP3CHIKV-WT, -F3AN, -F3AC or -F3ANC. Cells were lysed at 24hpt and 
subjected to immunoprecipitation with anti-GFP antibody. Then, samples were separated by SDS–PAGE and 
analyzed by immunoblot for GFP, G3BP-1 or actin as indicated. (C) BHK cells were mock-transfected or 
transfected with infectious clone plasmids expressing replication-competent RNA of CHIKV-wt, -F3AN, -
F3AC or -F3ANC, followed by fixation and immunofluorescence staining at 24hpt for nsP3CHIKV (green) and 
G3BP1 (red). Nuclei in blue. Scale bar, 10 µm.  
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compared to 48hpt for CHIKV-WT. This indicates that mutations in both FGDF motifs are 
lethal to CHIKV, likely due to the failure to bind and recruit G3BP. After plaque purification 
of virus from BHK cells transfected with the CHIKV-F3ANC infectious clone, reversion of the 
N-terminal FGDF motif was noticed by sequence analysis. Later, our collaborator’s results 
revealed another rescue strategy for CHIKV-F3ANC, supporting the conclusion that mutations 
in both FGDF motifs are lethal to CHIKV. The results from our collaborators also suggest the 
revision of N-terminal FGDF motif could be a consequence of CHIKV-F3AC contamination. 
This failure to rescue CHIKV-F3ANC precluded any experiment with the full panel of rescued 
CHIKV mutants. Therefore, the interaction of nsP3CHIKV and G3BP1 in the viral context was 
investigated by immunofluorescence after transfection with the CHIKV infectious clones in 
BHK cells. At 24hpt, cells were fixed and probed for nsP3CHIKV and G3BP1. Our results show 
that the G3BP1 signal colocalized with nsP3CHIKV-WT was strong, indicating efficient 
recruitment of G3BP1 to viral RCs, while the colocalization of the G3BP1 signal was weaker 
with nsP3CHIKV-F3AC and barely detectable with nsP3CHIKV-F3AN or nsP3CHIKV-F3ANC (Fig. 
5C). Thus, the properties of the FGDF-mediated interaction between nsP3 and G3BP are 
mostly conserved between nsP3SFV and nsP3CHIKV. Overall, these results demonstrate that the 
duplicate FGDF motifs in nsP3 are essential for efficient growth of SFV and CHIKV.  
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2.2 RESULTS PAPER II 
P-bodies are dynamic, non-membranous RNA granules in the cytoplasm. In order to investigate 
the fate of P-bodies during alphavirus infection, we first validated two commonly used P-body 
markers, Dcp1a and DDX6, in the cell lines used in this project, including MEFs (mouse 
embryo fibroblasts), BHK (baby hamster kidney cells) and U2OS (human bone osteosarcoma 
epithelial cells). Under normal conditions or after sodium arsenite (SA) treatment, P-bodies 
could be defined as discrete foci by immunofluorescence with antibodies for Dcp1a and DDX6, 
with both proteins colocalizing to a large extent in MEFs (Paper II, Fig. 1 (a)), BHK and U2OS 
cells (data not shown). It is worth mentioning that a small portion of P-bodies were stained only  
 
Fig. 6. Disassembly of P-bodies in cells upon infection with Old World alphaviruses, independent of viral 
structural proteins. (A) MEFs were mock-infected or infected with SFV-WT or CHIKV (MOI 1) for 8hpi 
prior to fixation and immunofluorescence staining of DDX6 (green, P-body marker) and dsRNA(red). (B) 
MEFs were mock-infected or infected with SFV-βGal (SFV expressing β-galactosidase instead of the viral 
structural proteins) at MOI 1. Cells were mock-treated or treated with SA (500 µM for 1h) before fixation at 
8hpi. Fixed cells were stained for Dcp1a (green), SFV-nsP3 (red) and TIA1 (blue). Scale bar, 10 µm. 
Representative pictures are shown. 
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by either Dcp1a or DDX6, probably due to the active exchange rate of the markers. In addition, 
a part of DDX6 was found in TIA1-stained SGs after SA stress, as previously reported 
(Kedersha et al. 2005). The P-body response was then tested upon infection with SFV or 
CHIKV. At 8hpi, infected MEFs were fixed for immunofluorescence analysis using anti-
DDX6 antibodies to probe for P-bodies and anti-dsRNA for viral infection. In contrast to mock-
infected cells, where P-bodies were consistently present, P-bodies were almost completely 
disassembled after infection with either SFV or CHIKV (Fig. 6A). Disassembly of P-bodies 
was also observed when the granules were defined by Dcp1a in SFV-infected MEFs (paper II, 
Fig. S1 (a)) or BHK cells (Paper II, Fig. S1 (b)). Previous studies have shown that alphavirus-
infected cells are incapable of forming SGs in response to SA (Panas et al. 2012). Therefore, 
we asked if P-bodies could be re-assembled in infected cells when stressed with SA. In response 
to SA, P-bodies increased in number and SGs were induced in mock-infected MEFs, while 
neither of the two granules re-appeared in response to SA in MEFs infected with SFV-WT 
(Paper II, Fig. 1 (c)) or CHIKV (Paper II, Fig. S1 (c)), suggesting that alphavirus-infected cells 
have lost the ability to react to a second stress by increasing the numbers of P-bodies or SGs. 
We then sought to determine which part of the virus was responsible for P-body disassembly. 
To this end, MEFs were mock-infected or infected with the virus recombinant SFV-bGal 
(Sjöberg et al. 1994), which expresses b-galactosidase instead of the viral structural proteins 
from the viral subgenomic region. Similarly to the situation with SFV-WT, nearly all P-bodies 
stained by Dcp1a were disassembled after infection with SFV-bGal (Fig. 6B). As seen after 
SFV-WT infection, re-induction of P-bodies by SA was blocked in SFV-βGal-infected cells 
(Fig. 6B). This indicates that the structural proteins of the virus are not necessary for the 
disassembly of P-bodies. 
As structural proteins are dispensable for P-body disassembly, we next tested how P-bodies 
respond to the expression of viral nsPs. An SFV trans-replication system was applied in these 
experiments. Briefly, the system consists of two plasmids for expression of nsPs (Rep, 
replicase) and delivery of a viral genome template, respectively (Utt et al. 2016). With the help 
of this system, expression of nsPs and replication of virus genomes can be disconnected by 
transfection of either only the plasmid for nsPs or both plasmids for nsPs and viral genome 
template. After transfection, SFV nsPs are expressed either alone or together with the viral 
genome template, in which the two ORFs were replaced with Firefly and Gaussia luciferase as 
reporters. MEFs were transfected with either the nsP expression plasmid alone (Rep-wt nsP1–
4) or the nsP plasmid plus viral genome template, fixed at 24hpt and subjected to 
immunofluorescence for dsRNA + nsP3 or Dcp1a + nsP3. The dsRNA signal was used to 
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assess proper formation of functional viral replicases, which has been shown to replicate both 
host and viral mRNA and thus generates dsRNA intermediates even in the absence of a viral 
RNA template (Nikonov et al. 2013). Indeed, dsRNA signals were observed and colocalized 
with nsP3 in cells transfected with either Rep-wt nsP1–4 alone or in combination with template, 
indicating the presence of functional viral replicases (Fig. 7A). As the viral genome template, 
but not host mRNA, carries the cis-elements for efficient replication, the dsRNA signal was 
stronger when viral genome template was provided (Fig. 7A). Nevertheless, there was no 
noticeable change of P-bodies (Dcp1a channel) in the transfected cells, neither with Rep-wt 
nsP1–4 alone nor in combination with template, compared to adjacent untransfected cells (Fig. 
7B). Our results indicate that expression of viral nsPs alone or together with the replication of 
viral template analogue is not sufficient to lead to P-body disassembly. Considering that the 
viral structural proteins are not required, we propose that replication of viral templates that 
carry proper nsP-encoding regions are required for P-body disassembly. 
In order to study at what time after infection P-bodies are disassembled, we performed time 
course experiments in which P-bodies were stained at different time points after infection with 
SFV-bGal at MOI 1, using antibodies for Dcp1a, nsP3 and TIA1 (as an SG marker). 
Disassembly of P-bodies was observed only in a few infected cells at 2.5hpi, and became 
dominant at 3.5hpi or later (Fig. 8A). At 3.5hpi and 4.5hpi, TIA1-positive SGs were induced 
in most infected cells concomitantly with P-body disassembly (Fig. 8A). P-body numbers per 
cell were quantified via CellProfiler for each group. The average number of P-bodies/ cell 
Fig. 7. P-bodies remain upon expression of alphavirus nsPs. MEFs were transfected with either Rep-wt or 
Rep-wt + template. At 24hpi, cells were fixed for immunostaining for dsRNA and SFV-nsP3 (A) or Dcp1a 
and SFV-nsP3 (B). Scale bar, 10 µm. Representative pictures are shown. 
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was 8.70 ± 0.56 (mean ± SEM, N=118) in mock-transfected cells, decreased at 2.5hpi (7.0 ± 
0.53 (mean ± SEM, N=115)) and dropped sharply and significantly at 3.5hpi and 4.5hpi to 3.42 
± 0.52 (N=93) and 1.15 ± 0.22 (N=120) (Fig. 8B). Thus, the average number of P-bodies/cell 
compared to mock-infected cells was reduced by 20% within 2.5h, by more than 60% within 
3.5h and by more than 80% within 4.5h. Importantly, at 3.5hpi and 4.5hpi the percentages of 
the infected cells containing ≤ 1 P-body/cell were 53% and 80% (see the distribution of the 
green dots in Fig. 8B), indicating that almost all P-bodies were disassembled in the majority of 
infected cells. The quantification results reveal that P-body disassembly in infected cells starts 
at 2.5hpi and that P-bodies are efficiently disassembled as early as at 3.5hpi. 
Fig 8. Disassembly of P-bodies occurs at early stage of viral infection. (A) MEFs were mock-infected or 
infected with SFV-βGal (MOI 1) and fixed at the indicated time points, followed by staining for Dcp1a (green), 
SFV-nsP3 (red) and TIA1 (blue). Representative pictures are shown. (B) Mean P-body numbers/cell ± SEM 
as quantified by CellProfiler based on the experiments shown in (A). The number of P-bodies for each analyzed 
cell are shown as green dots. Statistical analysis for infected cells in comparison to mock infection by unpaired 
Student’s t test, *p < 0.05, ****p < 0.0001. 
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Similar experiments were conducted with DDX6 as the marker of P-bodies. P-bodies defined 
by DDX6 were similarly present in mock-infected cells and infected cells at 2.5hpi (Paper II, 
Fig. 2 (b)). At 3.5hpi and 4.5hpi, bigger DDX6 foci appeared and colocalized with TIA1, 
indicating the localization of DDX6 in SGs (Paper II, Fig. 2 (b)). These DDX6/TIA1 puncta 
were confirmed to represent SGs by staining with another SG marker, eukaryotic initiation 
factor 3b (eIF3b; Paper II, Fig. S2), suggesting redistribution of DDX6 from P-bodies to SGs. 
These time course studies of P-body response, with either Dcp1a or DDX6 as a P-body marker, 
revealed that disassembly of P-bodies occurred at early stage (3–4h) post infection when or 
even before SGs were induced. Thus, the time point 3.5phi was used for the further 
investigations of the P-body response. 
DDX6 has been shown to be required for P-body formation (Ayache et al. 2015, Kamenska et 
al. 2016). Thus, we tested if disassembly of P-bodies during infection was a result of 
redistribution of DDX6 from P-bodies to SGs. To test this, we investigated the P-body response 
after infection with and without SG induction. Induction of SGs during alphavirus infection is 
mediated by phosphorylation of translation initiation factor 2 subunit a (eIF2a) on serine 51 
(McInerney et al. 2005). The P-body response to alphavirus infection was analyzed in SV129 
MEFs, where SGs cannot be induced due to the expression of a non-phosphorylatable eIF2a 
(MEFs-AA, Ser51Ala) (Scheuner et al. 2001). MEFs expressing wild-type eIF2a (MEFs-SS, 
Ser51) were included as controls. Without stress, P-bodies were similarly present in both cell 
lines (Paper II, Fig. 3 (a)). In response to SA, P-body numbers increased in both cell lines, but 
SGs stained by eIF3b were induced only in MEFs-SS but not MEFs-AA, as expected (Paper 
II, Fig. 3 (a)). At 3.5hpi with SFV-bGal, DDX6 foci in MEFs-SS colocalized with eIF3b, 
indicating induction of SGs and relocation of DDX6 from P-bodies to these SGs (Fig. 9A). 
However, in MEFs-AA cells, both DDX6 and eIF3b were largely diffused at 3.5hpi with SFV-
bGal infection, which indicates efficient disassembly of P-bodies and lack of SG induction 
(Fig. 9A). Similar results were obtained in MEFs-S/S and MEFs-AA after CHIKV infection 
(Paper II, Fig 3 (a)). Taken together, these results reveal that P-bodies are always disassembled 
after Old World alphavirus infection, regardless of SG induction.  
A recent study suggests that translation suppression mediated by the interaction between DDX6 
and 4E-transporter is required for P-body assembly (Ayache et al. 2015, Kamenska et al. 2016). 
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Host translation is dramatically inhibited during alphavirus infection, which was shown to rely 
on the phosphorylation of eIF2a (McInerney et al. 2005). We asked if host translation shutoff 
was related with P-body disassembly during infection. The translation status was assessed in 
SFV-bGal-, CHIKV- or mock-infected MEFs-SS and MEFs-AA by ribopuromycylation to 
assess active translation (David et al. 2012, Panas et al. 2015a). In the mock group, active 
translation was observed in each cell of both cell lines, visualized by the strong puromycin 
signal (Fig. 9B, and Paper II, Fig. 3 (b) and (c)). In MEFs-SS, the puromycin signal was reduced 
to an undetectable level after infection with either SFV-bGal at 3.5hpi or CHIKV at 5hpi, 
indicating significant repression of host translation (Fig. 9B, and Paper II, Fig. 3 (b) and (c)). 
In contrast, SFV-bGal- or CHIKV-infected MEFs-AA displayed similar ribopuromycylation 
as uninfected cells, due to the failure of efficient host translation shutoff (Paper II, Fig. 3 (b) 
and (c)). These results support the previous observation that host translation repression at early 
Fig 9. Disassembly of P-bodies is independent of SG formation or virus induced shutoff of host 
translation. (A) MEFs-SS or MEFs-AA were mock-infected or infected with SFV-βGal (MOI 10) and fixed 
at the indicated times for immunofluorescence. Cells were probed for DDX6 (green), dsRNA (red) and eIF3b 
(blue, SG marker). (B) MEFs-SS or MEFs-AA were mock-infected or infected with SFV-βGal (MOI 10). At 
the indicated time points, cells were ribopuromycylated (10µg/mL) for 5min before fixation. Fixed cells were 
probed for puromycin (green) and SFV-nsP3 (red). Scale bar, 10 µm. Representative pictures are shown. 
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times post Old World alphavirus infection is largely dependent on the phosphorylation of 
eIF2a (McInerney et al. 2005). Taken together, the results in Fig. 9 demonstrate that the 
alphavirus-induced P-body disassembly occurs immediately prior to or coincident with the 
shutoff of host protein translation and is independent of the phosphorylation of eIF2a.  
We next studied if disassembly of P-bodies was a result of alphavirus-infection-induced shutoff 
of host transcription. Bromo-UTP was used to label newly synthesized RNA (Panas et al. 
2015a), in order to study the transcription process during the P-body disassembly. We used 
BHK cells, which have higher transfection efficiency than MEFs, for this experiment. Time 
course studies of the P-body response in BHK cells revealed that P-bodies are mostly 
disassembled at 3–4hpi with SFV-bGal infection (Paper II, Fig. S4 (a)) and 4–5hpi with 
CHIKV infection (Paper II, Fig. S4 (b)). Thus, BHK cells infected with SFV-bGal or CHIKV 
were labelled by transfection with bromo-UTP at 3.5hpi and 4.5hpi, respectively, for 1h to 
study the RNA synthesis status. Mock-infected cells were also labelled with bromo-UTP in 
parallel and the results showed that the bromo-UTP signal was mainly concentrated in nuclei 
(Fig. 10A and Paper II, Fig. 4 (a) and (b)). In contrast, a sharp shift of the bromo-UTP signal 
from nucleus to cytoplasm was observed in cells infected with SFV-bGal (Fig. 10A) or CHIKV 
(Paper II, Fig. 4 (b)). The shift indicates that the active RNA synthesis in infected cells was 
mainly cytoplasmic, most likely as viral RNA replication. The massive reduction or almost 
complete lack of nuclear bromo-UTP signal in the infected cells indicates the effective shutoff 
of host transcription already at this early time in viral infection. The cytoplasmic bromo-UTP 
staining appeared in most double-positive cells (successfully infected and bromo-UTP 
labelled) with SFV-bGal infection, assuming that most cells were infected at a similar rate. In 
CHIKV-infected cells at 4.5hpi, the majority of double-positive cells (successfully infected and 
bromo-UTP-labelled) had bromo-UTP signals in the cytoplasm, though some double-positive 
cells still showed nuclear bromo-UTP signals (data not shown), probably due to slower 
progression of CHIKV infection. These results suggest that shutoff of host transcription caused 
by virus infection correlates with the disassembly of P-bodies at early stages of Old World 
alphavirus infection. 
Actinomycin D (ActD) at high concentration (5µg/mL) can inhibit transcription in cells by 
targeting all polymerases (Bensaude 2011). Earlier studies have observed a decrease in P-body 
numbers with ActD treatment in HEK293 cells (Cougot et al. 2004). We therefore tested how 
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P-bodies respond to ActD in BHK and compared the response with that after alphavirus 
infection. The inhibition effect of ActD was first validated in bromo-UTP labelling 
experiments. Without ActD, bromo-UTP was successfully incorporated into newly synthesized 
RNA and accumulated in the nucleus, while after 1h ActD treatment, there was no cell showing 
any bromo-UTP signal, indicating the effective suppression of transcription (Paper II, Fig. 4 
(c)). ActD treatment for 4h led to a clear decrease of P-body numbers in BHK cells (Fig. 10B), 
but failed to cause visible changes of P-bodies within a shorter time. P-body numbers/cell was 
quantified, yielding an average P-body number of 10.09 ± 0.39/cell (mean ± SEM, N=163) in 
cells treated with ActD for 4h, which is significantly lower than the P-body number in the 
control group (14.15 ± 0.69/cell, N=158) (Fig. 10B). These results show that P-bodies were 
decreased in number with ActD, consistent with previous observations in another cell line 
(Cougot et al. 2004). Sixteen hours of treatment with ActD almost depleted P-bodies in BHK 
cells (data not shown), which likely resulted from the toxicity of ActD, since the majority of 
cells had died at this time. In summary, the transcription shutoff induced by ActD reduced the 
average P-body numbers/cell (by 29% within 4h), but failed to disassemble P-bodies as 
efficiently as virus infection. Thus, these results suggest that alphavirus infection manipulates 
more pathways than only the transcription shutoff to induce efficient P-body disassembly. 
Figure 10. Virus-induced host transcription shutoff correlates with the disassembly of P-bodies. (A) 
BHK cells were mock-infected or infected with SFV-βGal (MOI 10). At 3.5hpi, cells were transfected with 
bromo-UTP (Br-UTP) to label newly synthesized RNA for 1h before fixation. Cells were then stained for Br-
UTP (green) and SFV-nsP3 (red). (B) Left-hand side: BHK cells were mock-treated (DMSO) or treated with 
actinomycin D (5µg/mL) and fixed at different time points (1h, 2h, 4h, 8h, 16h). Fixed cells were stained with 
dual P-body markers Dcp1a (green) and DDX6 (red). Representative figures after 4h ActD or DMSO treatment 
were shown. Right-hand side: Mean P-body numbers/cell ± SEM as quantified by CellProfiler based on 
immunofluorescence. Numbers of P-bodies for each analyzed cell are shown as green dots. Statistical analysis 
by unpaired Student’s t test, ****p < 0.0001. 
 36 
Next, we attempted to mimic the viral effect on P-body disassembly using a panel of 
pharmacological treatments. Thus, cycloheximide (CHX) and puromycin were used to assess 
the P-body response to the change of free cytoplasmic mRNA. Also, the P-body response to 
the modulation of nuclear transport was addressed by using leptomycin B, targeting CRM1-
mediated nuclear export (Nishi et al. 1994, Kudo et al. 1999), and importazole, targeting 
importin-mediated nuclear import (Soderholm et al. 2011). The active cytoplasmic RNA 
synthesis described above may also indicate potential damages to transport between cytoplasm 
and nucleus in virus-infected cells, which might affect P-bodies in addition to transcription 
shutoff. MEFs were mock-treated or treated with either of these drugs and subsequently 
analyzed by immunofluorescence and quantification of P-body numbers/cell (Fig. 11A/B). P-
bodies were consistently present in the control group with 26.77 ± 1.81 P-bodies/cell on 
average (mean ± SEM, N=62). With CHX treatment, P-bodies were almost completely 
disassembled, confirming reports in previous studies (Sheth et al. 2003, Cougot et al. 2004). 
P-body numbers/cell dropped to 1.83 ± 0.50 after CHX treatment (mean ± SEM, N=58). A 
robust decrease of P-bodies was only observed after 4h treatment with puromycin (Paper II, 
Fig. S5 (a), puromycin 4h), but not within a shorter time (1h and 2h, data not shown), a decrease 
at a similar rate as with ActD (Paper II, Fig. S5 (a), ActD 4h). P-body response to different 
concentrations of leptomycin B (5ng/mL, 10ng/mL and 20ng/mL) were analyzed for various 
treatment times (1h, 2h, 4h and 6h). There was no noticeable change of P-bodies between the 
control cells and leptomycin-B-treated cells (paper II, Fig. S5 (b)). The results suggest that P-
bodies are practically insensitive to the interference with nuclear export by leptomycin B, as 
previously reported (Ferraiuolo et al. 2005). In addition, P-body response to treatment with 
importazole was assessed using different incubation times (15min, 30min, 1h, 2h and 4h) and 
serial concentrations (25µM, 50µM, 75µM and 100µM). Interestingly, treatment with 
importazole for 15min resulted in almost complete P-body disassembly at concentrations of 
50µM or more, but not 25µM (Fig. 11A). P-body numbers/cell decreased to 1.5 ± 0.30 (mean 
± SEM, N=58) after treatment with 75µM importazole for 15min. TIA1 was included as an SG 
marker in all experiments, and the results showed that SGs were not induced under any 
treatment, i.e. CHX, Puro, ActD, leptomycin B or importazole (Fig. 11 and paper II, Fig 5a, 
S5a and S5b, TIA1 channel).  
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Fig 11. P-body response to multiple stress conditions. (A) Top panel: MEFs were treated with CHX (10 µg/mL 
in DMSO), importazole (75 µM in DMSO) or DMSO (0.15%, contol treatment) for the indicated period of time 
before fixation, followed by staining for Dcp1a (green), DDX6 (red) and TIA1 (blue). Middle panel: After the 
treatment described in the top panel, MEFs were stressed with SA (500 µM) in the presence of the indicated drugs 
for 30min, fixed and probed for Dcp1a (green) and DDX6 (red). Bottom panel: After the treatment described in 
the top panel, CHX, importazole or DMSO was removed and replaced with warm normal culture medium. Cells 
were further cultured and fixed after a recovery time of 15min. Fixed cells were probed for Dcp1a (green) and 
DDX6 (red). Scale bar, 10 µm. Representative images are shown. (B) Mean P-body numbers/cell ± SEM as 
quantified by CellProfiler based on the experiments shown in (A). Drug-treated groups were compared to the 
DMSO control group under the same conditions. Numbers of P-bodies for each analyzed cell are shown as green 
dots. Statistics: unpaired Student’s t test, ns p>0.05, *p < 0.05, ****p < 0.0001. 
 
As shown above, re-induction of P-bodies and SGs with additional SA treatment is not 
observed in alphavirus-infected cells. We next tested whether P-bodies and SGs can be re-
induced with SA upon the drug treatments that lead to reductions or efficient disassembly of 
P-bodies (CHX, puromycin, ActD and importazole). When control cells were stressed with SA, 
average P-body numbers were almost doubled to 37.18 ± 1.936 (mean ± SEM, N=60) and SGs 
were induced (Fig. 11A, DMSO + SA, second row; Fig. 11B). In the presence of CHX, re-
induction of either P-bodies or SGs by sodium arsenite was efficiently blocked (Fig. 11A, CXH 
+ SA), similarly as previously observed (Kedersha et al. 2000). Average numbers of P-
body/cell were quantified as 1.5 ± 0.38 (mean ± SEM, N=60) (Fig. 11B). Puromycin treatment, 
however, did not prevent SG and P-body induction by SA, with similarly increased P-body 
numbers and formation of SGs as in the control cells (Paper II, Fig S5 (a), puromycin 4h + SA). 
Cells stressed with sodium arsenite in the presence of ActD showed an increase in P-body 
numbers, but did not form SGs (Fig S5 (a), ActD 4h + SA). Re-induction of P-bodies and SGs 
was, however, largely inhibited in the presence of importazole: The response to SA was either 
completely abolished or dramatically inhibited with no or much lower P-body and SG re-
induction compared to the control cells (Fig. 11A, importazle + SA). The average number of 
P-bodies/cell was 13.63 ± 1.10 in importazole-treated, SA-stressed cells (mean ± SEM, N=71) 
(Fig. 11B). Even though there was an increase in P-body numbers by SA stress in importazole-
treated cells, the average P-body counts only reached approximately one third of the values in 
SA-stressed control cells. Thus, the capacity of cells to re-form P-bodies was strongly 
compromised when nuclear import was inhibited with importazole. 
Rapid disassembly of P-bodies was observed with either CHX or importazole treatment. We 
then asked whether the effect of CHX or importazole was reversible and whether P-bodies 
could re-assemble after drug removal (Fig. 11A, third row). When CHX was removed, P-
bodies were restored within 15min to average P-body numbers of 16.90 ± 1.10 (mean ± SEM, 
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N=73) per cell (Fig 11B). After removal of importazole P-bodies recovered rapidly (within 
15min) with 24.42 ± 1.3 (mean ± SEM, N=69) P-bodies/cell (Fig 11B). These values are 
comparable to the numbers under control conditions (23.32 ± 1.62 P-bodies/cell, mean ± SEM, 
N=62, Fig. 11B).  
The results obtained with importazole reveal nuclear import as a previously unrecognized 
pathway involved in P-body dynamics. To exclude cell line specificity, we tested the P-body 
response to importazole also in BHK cells and observed similar P-body disassembly after 
15min treatment of importazole (Paper II, Fig. S5 (c)), supporting that nuclear import is a novel 
pathway involved in the P-body dynamics.  
In summary, these results reveal that treatment with either CHX or importazole leads to an 
efficient and mostly reversible disassembly of P-bodies, which resembles the P-body 
disassembly efficiency that is observed upon alphavirus infection. This suggests that alphavirus 
infection may induce P-body disassembly by inhibiting host cell translation (like CHX), 
transcription (like ActD) as well as nuclear import (like importazole).
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2.3 RESULTS PAPER III 
In our previous work, we showed that infection of cells with SFV but not CHIKV leads to 
strong and persistent activation (“hyperactivation”) of the PI3K–Akt–mTOR pathway and 
concomitantly internalization of RCs. The phenotype was attributed to the HVD in SFV nsP3 
since PI3K–Akt–mTOR hyperactivation and RC internalization are largely abolished in the 
SFV-Δ50 mutant, in which 50 residues at the beginning of the HVD are deleted (see Fig. 12A) 
(Thaa et al. 2015). We set out to identify a sequence feature in this part of nsP3 that is present 
in SFV but absent in CHIKV and might be relevant for the phenotypic differences. Upon 
alignment of the sequences of the C-terminal region of SFV and CHIKV nsP3 (Fig. 12A), we 
noted that the sequence of SFV but not CHIKV nsP3 contains the sequence Y369-E370-P371-
M372 (yellow in Fig. 12A). This corresponds to a YXXM motif, a well-characterized 
activation motif for PI3K–Akt when the tyrosine is phosphorylated (Fruman et al. 1998). 
Although this motif is present in SFV-∆50, it is likely to be in an unfavorable structural context 
because the deletion starts within the structured zinc-binding region of the protein and because 
Y369 is the first residue after the 50 residues deleted in SFV-∆50 (grey in Fig. 12A). We 
hypothesized that hyperactivation of the PI3K–Akt–mTOR pathway during SFV infection 
could be attributed to the YEPM motif in SFV nsP3. To test the hypothesis, we generated viral 
mutants containing mutations at Y369, with an exchange of this tyrosine residue either to 
alanine (SFV-YA) or to phenylalanine (SFV-YF), which is structurally more similar to 
tyrosine. We mock-infected or infected BHK cells with wild type SFV (SFV-WT), SFV-YA 
or SFV-YF at an MOI of 10. Cells were lysed at 8hpi for analysis of Akt phosphorylation by 
Western blotting (Fig. 12B). At 8hpi, Akt was strongly phosphorylated in cells infected with 
SFV-WT, confirming Akt hyperactivation. Upon infection with SFV-YA or SFV-YF however, 
the intensity of the phospho-Akt signal was much lower, indicating weaker activation of PI3K–
Akt (Fig. 12B, left-handed panel). Infection was firmly established in each case, as judged from 
the nsP3 signals. Densitometry analysis showed that levels of Akt phosphorylation induced by 
SFV-YA and SFV-YF were less than half of those for SFV-WT (Fig. 12B, right-handed panel) 
and only slightly above background. Consistent with low PI3K–Akt activation, viral RCs of 
SFV-YA and SFV-YF were mainly localized at the cell periphery, while SFV-WT showed 
efficient RC internalization, based on the results of dsRNA staining (Fig. 12C). Taken together, 
these results strongly suggest that Y369 in SFV nsP3 is the key residue for the Akt 
hyperactivation phenotype. We further confirmed that expression of nsP3 alone is sufficient 
for PI3K–Akt–mTOR hyperactivation when a membrane anchor is provided that mimics 
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Fig. 12. (A) Alignment of the C-terminal regions of SFV-nsP3 (GenBank accession number AKC01667) and 
CHIKV-nsP3 (GenBank accession number ABX40005). Highlighted sequence features: Deletion of 50 amino 
acids in SFV-Δ50 (gray background); tyrosine (Y369) in the context of a YXXM motif (yellow, only in SFV); 
prolines in the proline-rich region (green); FGDF motifs (red). (B) BHK cells were infected with SFV-WT, SFV-
YA (nsP3 Y369A) or SFV-YF (nsP3 Y369F) at MOI 10 or mock-infected, lysed at 8hpi, followed by Western 
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blot analysis for the indicated proteins. Representative blot in the top panel; densitometry of the intensities of P-
Akt bands (normalized to the respective total Akt signal), shown relative to SFV-WT. Data are averages from two 
independent experiments ± SEM. Dashed line: Average P-Akt signal intensity in mock-infected controls. (C) BHK 
cells were mock-infected or infected with the indicated viruses at MOI of 10 and fixed at 8hpi followed by 
immunofluorescence for dsRNA to stain viral replication complexes (red). Nuclei in blue. Scale bar, 10 µm. (D) 
MEFs were mock-transfected or transfected with indicated plasmids encoding FLAG-tagged nsP3-wt, Myr-Pal-
nsP3-wt or Myr-Pal-nsP3-YF. Cells were fixed at 24hpt and stained for phospho-Akt (S473, green) and FLAG-
nsP3 (red). Nuclei in blue. Scale bar, 20µm. (E) BHK cells were mock-infected or infected with SFV-WT or SFV-
YF at MOI 10 for 1h; incubation was done in normal growth medium until 4hpi and then continued in normal 
growth medium (no starvation) or EBSS (starvation) for another 4h prior to lysis at 8hpi and Western blotting for 
the indicated proteins. 
 
membrane attachment of the RC. Strong Akt phosphorylation was detected by 
immunofluorescence in cells transfected with Myr-Pal-SFV-nsP3-wt, which carries a 
membrane anchor (myristoylation and palmitoylation), but neither in cells expressing SFV-
nsP3 without this membrane anchor nor in cells expressing Myr-Pal-SFV-nsP3 with mutated 
Y369 (Fig. 12D). The Y369A and Y369F mutations were similarly effective at destroying the 
PI3K–Akt–mTOR hyperactivation phenotype. To minimize the potential of unrelated 
structural changes by the mutation, we selected SFV-YF for further experiments.  
In order to test how the mutation Y369F in nsP3 affects viral replication, we next performed 
growth curve experiments. BHK cells were infected with SFV-WT, SFV-YF or SFV-Δ50 at 
MOI 0.1 or MOI 10; supernatants were harvested at different time points post infection and 
used for quantification of viral titers by plaque assay. SFV-YF was clearly attenuated with 
respect to SFV-WT at later times. SFV-Δ50 was more attenuated than SFV-YF, possibly due 
to additional malfunction other than the weaker PI3K–Akt activation (Paper III, Fig. 3G and 
3H). Previously, we reported that infection with SFV-WT but not SFV-Δ50 keeps the 
metabolic regulator mTOR active even under conditions of nutrient starvation, where mTOR 
is normally inactive (Thaa et al. 2015). We hence compared the ability of SFV-WT and SFV-
YF to activate the PI3K–Akt–mTOR pathway in both normal growth conditions and starvation. 
BHK cells were mock-infected or infected with SFV-WT or SFV-YF at MOI 10. At 4hpi 
medium was replaced by either standard growth medium or salt solution without any nutrients 
or growth factors (EBSS), incubation was continued for an additional 4h until lysis at 8hpi and 
Western blot analysis. In addition to Akt phosphorylation, phosphorylation of the ribosomal 
protein S6 was also probed as a downstream readout of mTORC1 activation (Fig. 12E). The 
results show that in cells infected with SFV-WT, Akt was strongly phosphorylated both under 
standard nutrient conditions and starvation conditions, and mTOR was active under both of 
these conditions as evidenced by strong phospho-S6 signals, confirming our earlier 
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observations (Thaa et al. 2015). In cells infected with SFV-YF in standard medium, Akt was 
again phosphorylated to a lesser degree than with SFV-WT; mTOR was active under these 
conditions as judged from the strong S6 phosphorylation. Upon starvation however, SFV-YF-
infected cells neither showed any Akt phosphorylation above background level nor any S6 
phosphorylation, similar to mock-infected starved cells and indicating that mTOR was inactive 
under these conditions. These results show that Y369 is necessary for efficient viral replication 
and hyperactivation of PI3K–Akt–mTOR during SFV infection. 
 
 
It has been well studied that activation of PI3Ks (class IA) can be mediated through the 
interaction between the phosphorylated tyrosine in a YXXM motif and the SH2 domain of the 
p85 subunit of PI3K (Fruman et al. 1998). Tyrosine phosphorylation of SFV nsP3 has never 
been reported (Peränen et al. 1988; Vihinen and Saarinen. 2000), but the phenotype of SFV-
YF compared to SFV-WT suggests that SFV-nsP3 binds p85 through such an interaction, and 
that either mutation at Y369 in nsP3 or mutations in the SH2 domains of p85 would abolish 
the interaction. To test this, we transfected HEK293 cells with a plasmid for expression of the 
Fig. 13: Binding of nsP3 and p85, dependent on Y369 in nsP3 and SH2 domain in p85. (A and B) 
HEK293 cells were co-transfected with the indicated combinations of plasmids. All p85 constructs were N-
terminally tagged with EYFP; pEGFP-C1 served as control. pcDNA3.1-Myr-Pal-nsP3 encodes nsP3 with N-
terminal myristoylation and palmitoylation signal; pEBB/PP-nsP3 encodes nsP3 with an N-terminal biotin 
acceptor peptide (BAP); pcDNA3.1(–) served as empty vector control. At 24hpt, cell lysates were prepared 
and subjected to immunoprecipitation (IP) with anti-GFP antibody for pulldown of EGFP and EYFP-tagged 
p85, followed by probing of IPs and lysates for GFP, nsP3 and actin by Western blot. (C) BHK cells were 
mock-infected or infected with SFV-WT or SFV-YF at MOI 10. Cells were lysed at 8 hpi, followed by 
immunoprecipitation with anti-p85 antibodies, and by Western blot for probing for SFV-nsP3, p85 and actin. 
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p85 isoform p85-a with an N-terminal EYFP tag plus plasmids for expression of either Myr-
Pal-nsP3-wt, Myr-Pal-nsP3-YF or nsP3-wt without membrane anchor or empty plasmid 
(pcDNA3.1). We lysed the transfected HEK293 cells at 24hpi, followed by 
immunoprecipitation with anti-GFP antibodies, which cross-react with the EYFP tag in p85-α. 
Cell lysates and immunoprecipitation samples were analyzed by Western blot for GFP (to 
detect EYFP-p85-α), nsP3 and actin (Fig. 13A). The results revealed that Myr-Pal-nsP3-wt was 
efficiently co-immunoprecipitated with EYFP-p85-a, while both Myr-Pal-nsP3-YF and nsP3-
wt without Myr-Pal signal failed to do so, indicating that interaction between nsP3 and p85 
requires both Y369 and the membrane localization. Next, we tested whether the interaction 
between nsP3 and p85-a was dependent on the SH2 domains in p85-a. In the two SH2 domains 
of p85-a, the arginine residues in the FLVRD/E motifs are required for the interaction between 
p85 and phospho-tyrosine, and the interaction is abolished when arginine is mutated to alanine 
in both SH2 domains (“RARA mutant”, (Yu et al. 1998, Luo et al. 2005)). Thus, we transfected 
HEK293 cells with Myr-Pal-nsP3-wt expression plasmids plus expression plasmids for EGFP, 
pEYFP-tagged p85-α-wt or the RARA mutant, followed by cell lysis and immunoprecipitation 
with anti-GFP (Fig. 13B). Myr-Pal-nsP3-wt was bound to EYFP-p85-a-wt, but not EYFP-p85-
a-RARA or GFP alone, indicating the requirement of the SH2 domains in p85 for the 
interaction (Fig. 13B). Since there are two isoforms of p85, we also performed 
immunoprecipitation experiments for SFV-nsP3 and the other p85 isoform, p85-β, analogous 
to the experiments shown in Fig. 13B. Similar results were obtained as those of p85-a: Myr-
Pal-nsP3-wt was pulled down with the p85-β probe, but not the YF mutant or nsP3 without 
membrane anchor (Paper III, Fig. 3D). Last, we determined if the interaction between nsP3 and 
p85 also occurs during viral infection. BHK cells were mock-infected or infected with SFV-
WT or SFV-YF at MOI 10 and lysed at 8hpi for immunoprecipitation with anti-p85 antibodies 
and subsequent Western blot (Fig. 13C). Even though the endogenous levels of p85 in the cell 
lysates and immunoprecipitation samples were barely detectable by Western blot, probing the 
p85 immunoprecipitates with anti-nsP3 antibodies showed clear interaction between p85 and 
nsP3 in SFV-WT infection, while no interaction between p85 and nsP3 was observed in lysates 
of SFV-YF-infected cells (Fig. 13C). These data collectively demonstrate that SFV 
hyperactivates the PI3K–Akt–mTOR pathway through the interaction between SFV-nsP3 and 
the p85 regulatory subunit of PI3K, in a manner that is dependent on membrane localization of 
nsP3 and on both Y369 in nsP3 and the SH2 domains in p85. The results are also indirect proof 
that Y369 in SFV nsP3 is phosphorylated, at least transiently, because SH2 domains bind 
phospho-tyrosines in YXXM motifs (Fruman et al. 1998). 
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Further, the biological relevance of this interaction between SFV nsP3 and p85 was studied in 
paper III. One such feature is the downstream activation of mTOR, which is involved in 
translational control, mediated for instance by phosphorylation of the ribosomal protein S6. As 
shown above in Fig. 12E, mTOR remained active even under conditions of nutrient and growth 
factor depletion in cells infected with SFV-WT but not SFV-YF, evidenced by sustained S6 
phosphorylation. Through collaboration, PI3K–Akt–mTOR hyperactivation upon SFV 
infection was in addition linked to metabolic reprogramming of cells. Mass-spectrometry-
based metabolomics revealed that glycolysis was strongly up-regulated in cells infected with 
SFV-WT, also leading to increased fatty acid, amino acid and nucleotide levels (Paper III, Fig. 
1). This activation of glycolysis was much lower upon inhibition of PI3K–Akt signaling with 
wortmannin (Paper III, Fig. 2) and upon infection of cells with SFV-YF (Paper III, Fig. 4). 
The YXXM motif is not conserved in all Old World alphaviruses. The motif is absent in nsP3 
of CHIKV (Fig. 12A) and most other Old World alphaviruses, but present in the important 
human pathogen RRV as YETM (Fig. 14A, in yellow). To analyze whether RRV infection also 
leads to hyperactivation of the PI3K–Akt–mTOR pathway by the YXXM-mediated 
mechanism, BHK cells were mock-infected or infected with either RRV-WT or RRV-YF, a 
mutant in which the YXXM tyrosine in nsP3 of RRV was replaced by phenylalanine by means 
of reverse genetics. Western blot results showed strong and persistent Akt phosphorylation in 
BHK cells infected with RRV-WT but not RRV-YF (Fig. 14B). Staining for dsRNA at 8 hpi 
show that RCs of RRV-WT but not RRV-YF were efficiently internalized from the cell 
periphery (Fig. 14C). Next, we compared the ability of RRV-WT and RRV-YF to activate 
mTOR upon starvation. BHK cells were mock-infected or infected with RRV-WT or RRV-YF 
at MOI 5. At 4hpi growth medium was replaced by either standard medium or EBSS. Cells 
were lysed at 8hpi and processed for Western blot analysis (Fig. 14D). The results showed that 
infection with RRV-WT led to high phosphorylation levels of both Akt and S6 under normal 
and starvation conditions, indicating sustained PI3K–Akt–mTOR activation even during 
starvation. Infection with RRV-YF induced low phosphorylation levels of Akt in non-starved 
cells and background Akt activation in starved cells. S6 phosphorylation was high under 
standard conditions and very low under starvation, similar to the situation in mock-infected 
cells. These data support that Y356 in RRV nsP3 is analogous to Y369 in SFV nsP3 to mediate 
hyperactivation of the PI3K–Akt–mTOR pathway. Thus, this phenotype is not only seen in 
SFV, but also in the human pathogen RRV. 
Through collaboration, the PI3K–Akt–mTOR hyperactivation by RRV-WT was linked to 
pathogenesis in an in vivo mouse model of infection. RRV-YF was clearly attenuated in 
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comparison to RRV-WT in mice, evidenced by significantly lower disease scores and thus less 
pronounced limb weakness and less severe loss of gripping ability, as well as slightly lower 
viremia (Paper III, Fig. 7). 
 
 
Fig. 14: Ross River virus has the same phenotype as SFV regarding PI3K–Akt hyperactivation and 
replication complex internalization. (A) Alignment of the C-terminal regions of SFV-nsP3 (GenBank 
accession number AKC01667) and RRV-nsP3 (UniProtKB/Swiss-Prot: P13888.1). Highlighted sequence 
features as in Fig. 12A. (B) BHK cells were mock-infected or infected with RRV-WT or RRV-YF (nsP3 
Y356F) at MOI 5 and lysed at 8hpi. Cell were lysed and probed with the indicated antibodies by Western 
blot. (C) BHK cells were infected with RRV-WT or RRV-YF at MOI 5 and fixed at 8hpi., followed by 
immunofluorescence staining for dsRNA (red). Nuclei in blue. Scale bar, 10 µm. (D) BHK cells were mock-
infected or infected with RRV-WT or RRV-YF at MOI 5 for 1 h; cells were incubated in standard growth 
medium until 4hpi and then continued in standard growth medium (no starvation) or EBSS (starvation) for 
another 4 h, followed by lysis (at 8hpi) and Western blotting for the indicated proteins. 
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Taken together, the results of paper III show that PI3K–Akt–mTOR hyperactivation, observed 
with SFV and RRV, is connected to metabolic alterations and pathogenicity. As revealed in 
paper III, the molecular reason for this PI3K–Akt–mTOR hyperactivation is the interaction of 
a phospho-tyrosine in the viral protein nsP3 in the context of a YXXM motif with the SH2 
domains of p85, the regulatory subunit of PI3K. 
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3 DISCUSSION  
The results presented in this thesis demonstrate how Old World alphaviruses explore different 
cellular pathways in order to create a suitable environment for efficient establishment of virus 
infection.  
In paper I, we compared the duplicate motifs FGDFN and FGDFC in alphavirus nsP3 with 
respect to G3BP1 binding, using a panel of four variants (WT and mutations of either or both 
of the motifs) in different contexts – in vitro studies with purified proteins, experiments with 
transfected cells and with viruses. The results of all the experiments show that the two FGDF 
motifs consistently differ in their binding capacity to G3BP1. After transient expression in cells, 
recombinant proteins containing an intact FGDFN always bound more G3BP1 than those 
corresponding proteins with just an intact FGDFC motif or no intact FGDF motif. The results 
from MST tests with purified recombinant proteins also revealed that FGDFN has higher 
binding affinity to G3BP than FGDFC. Interestingly, transiently expressed nsP3-F3AC variants 
(containing functional FGDFN) bound similar or even higher levels of G3BP1 than WT nsP3, 
even though both FGDF motifs are present in WT nsP3. However, in the context of virus 
infection, only half as much G3BP1 was bound by nsP3-F3AC compared to WT nsP3. The 
difference between transient expression and virus infection is likely due to the different 
expression levels and/or protein processing of nsP3. When transiently expressed, nsP3 is 
usually overexpressed on its own. Thus, there is no restriction for nsP3 to bind G3BP1, as long 
as FGDFN is intact. G3BP1 might be the limiting factor in this case. This may explain why 
nsP3-F3AC binds as much G3BP1 as WT nsP3. In contrast, expression levels of nsP3 during 
infection are well regulated together with the other nsPs, and the expression of the nsPs is 
overall maintained at a relatively low level. Despite these low expression levels of nsP3 in the 
context of virus infection, G3BP can still be efficiently recruited by nsP3 during virus infection, 
which may be attributed to the fact that duplicate FGDF motifs have evolved in alphavirus 
nsP3.  
During virus infection, the efficient recruitment of G3BP1 to nsP3 is dependent on the duplicate 
FGDF motifs, which leads to the formation of G3BP:nsP3 complexes, probably already at quite 
early stages of infection. As depicted in our crystal structure, the G3BP:nsP3 complexes may 
build up higher-order oligomers, but only when both FGDF motifs are present. The biological 
studies in paper I suggest the formation of oligomers is strongly related to virus growth, which 
could contribute to establish early virus infection. Virus mutants lacking either or both of the 
FGDF motifs are all strongly attenuated. Especially for CHIKV, mutations in both FGDF 
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motifs are lethal for the virus, indicating the extreme dependence of virus infection on the 
binding of nsP3 to G3BP1. In SFV- or CHIKV-infected cells, some of the nsP3:G3BP puncta 
also stain for dsRNA (Panas et al. 2012), suggesting an important role for G3BP in the 
replication of viral RNA. Our previous studies have shown that alphavirus infection can 
efficiently disassemble SGs by capturing G3BP via the FGDF motifs in nsP3 (Panas et al. 
2012, Panas et al. 2015b). The formation of G3BP:nsP3 oligomers probably facilitates a stable 
sequestration of G3BP, keeping it inaccessible for SG formation. This would help the virus to 
ensure a rapid and sufficient counteraction of SG formation. 
Other host and viral factors could also be involved in or recruited to G3BP:nsP3 complex. Our 
crystal structure was achieved from the NTF2-like domain of G3BP and a short region of the 
nsP3 HVD. Both G3BP and nsP3 consist of more domains in addition to those used to obtain 
the crystal structure. Importantly, both proteins contain various intrinsically disordered regions 
with quite flexible structural conformation. These regions are seen as interaction hubs, where 
protein–protein interactions can be adapted. For example, a recent study of G3BP revealed its 
interaction with 40S ribosome subunits (Kedersha et al. 2016), suggesting the recruitment of 
these translation factors to virus replication sites. This would enable immediate translation of 
newly produced viral RNA and increase the translation efficiency, which could play important 
roles for early establishment of infection. Alphavirus nsP3 has been predicted to be largely 
disordered in its HVD region, and dozens of host factors have been identified as potential 
interaction partners (reviewed in (Götte et al. 2018)). Also, nsP3 is usually seen in virus 
replication complexes together with other nsPs. Hence, the G3BP:nsP3 complex could also 
help in the organization of viral replicases, e.g. by optimizing its conformation. Thus, the 
knowledge derived from paper I, especially the spatial organization of G3BP:nsP3 complexes, 
provides an important platform for further investigations on the composition of viral replication 
complexes and the potential roles of G3BP and other cellular factors. 
Paper II 
Many viruses manipulate P-bodies during infection, indicating the P-body response as a 
conserved and important host reaction against viral infection. In paper II, we describe the 
efficient P-body disassembly in a variety of cells infected with Old World alphaviruses (SFV 
or CHIKV). Our results add more support to the significance of the P-body response during 
viral infection. However, the mechanisms of P-body modulation during infection remain 
largely unknown. Dougherty and colleagues found the accelerated degradation of potential P-
body scaffold proteins during poliovirus infection, including Dcp1a, XRN1 and the 
deadenylase complex component Pan3 (Dougherty et al. 2011)
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upon poliovirus infection was suggested as a potential mechanism of P-body disassembly 
(Dougherty et al. 2011), considering that deadenylation has been shown to be required for P-
body formation (Zheng et al. 2008). A subsequent study of Dougherty and colleagues proposed 
that disassembly of P-bodies is mainly attributed to the functions of multiple viral proteases, as 
individual expression of viral proteases, including 3CD, 2Apro and 3Cpro, repressed or 
dispersed P-bodies (Dougherty et al. 2015). In our studies in the alphavirus context, we tested 
the protein levels of the P-body components DDX6 and Dcp1a at different time points (2, 4, 6, 
8h) after infection with SFV. Both proteins remained rather stable over this period of time and 
were still present even when P-bodies were disassembled (data not shown). Hence, P-body 
components are unlikely targeted for accelerated degradation by any viral protease in 
alphavirus infection. 
We investigated what virus parts are required for infection-induced P-body disassembly. 
Results from SFV-bGal showed that the expression of viral structural proteins is not required 
for the disassembly of P-bodies during infection with SFV (Fig. 6). Also, the P-body response 
was tested upon transient expression of all four nsPs, which are capable of forming functional 
viral replicases (Nikonov et al. 2013). This condition resembles the events at the early stage of 
infection. Upon expression of SFV nsPs, with or without viral genome template, dsRNA could 
be detected, confirming the formation of functional viral replicases. Yet, functional viral 
replicases obtained by transient expression of all nsPs failed to induce efficient disassembly of 
P-bodies (Fig. 7). It has to be noted, though, that these tools (SFV-bGal, trans-replication 
system) do not efficiently reproduce all aspects of natural infection. For instance, expression 
levels of viral proteins may differ from those in virus infection, and the replication efficiency 
in the trans-replication system is probably lower than in virus infection. Further, the regulation 
of the viral replicase may be different in the trans-replication system because a random reporter 
mRNA (for Firefly luciferase in this case) is generated instead of the non-structural mRNA that 
is produced upon infection with SFV-WT or SFV-βGal. Also, the viral non-structural ORF is 
much longer than the reporter gene, and the length of the virus genome can affect the size of 
virus-induced spherules and hence possibly the efficiency of downstream effects (Kallio et al. 
2013). These limitations may have affected the efficiency of replication in the experiments. 
Proper and/or robust replication of the virus genome and features of the original viral RNA 
might be required for alphavirus-induced P-body disassembly.  
Results from time course studies show that P-bodies are disassembled at a very early stage of 
infection (Fig. 8). Our previous studies have shown that SGs are induced at a similarly early 
stage of infection (McInerney et al. 2005, Panas et al. 2012). Many factors, including DDX6, 
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are known to be present in both types of granules under stress (reviewed in (Decker and Parker. 
2012, Stoecklin et al. 2013, Ivanov et al. 2018)). DDX6, which has recently been suggested to 
be critical for P-body formation, was colocalized with SG markers when P-bodies were 
disassembled during SFV-bGal infection (paper II, Fig. 2 (b)). This all suggests some 
interdependence of SGs and P-bodies in the context of alphavirus infection. We therefore tested 
if the virus-induced disassembly of P-bodies was dependent on the virus-induced formation of 
SGs. To this end, we studied the P-body response in MEFs-AA cells, where SGs cannot be 
formed after Old World alphavirus infection, in comparison to wildtype MEFs (MEFs-SS). 
The results of these experiments show that P-bodies were equally disassembled after infection 
regardless of whether SGs can be induced or not. This, however, does not exclude potential 
communication between P-bodies and SGs during infection, since both granules are highly 
dynamic and can change within minutes. In consistence with this feature, an interesting 
phenomenon in our experiments was that in infected cells, P-bodies were either in their 
“normal” state (like in non-infected cells) or completely disassembled, but very rarely in an 
intermediate phase. These results indicate that disassembly of P-bodies happens so fast during 
infection that time course staining may not be able to catch the process. Thus, live-cell imaging 
might be a better way to study the dynamics of P-bodies during infection.  
Through live-cell imaging studies, P-bodies were observed to be physically correlated with 
SGs under stress conditions (Kedersha et al. 2005). FRAP (fluorescence recovery after 
photobleaching) results indicate that the P-body factor Dcp1a shuttles between P-bodies and 
the cytosol as fast as within seconds (Kedersha et al. 2005, Aizer et al. 2008). The movement 
of most P-bodies is confined. P-body movement is associated with and also dependent on 
microtubule networks, as disruption of the microtubule network by nocodazole disrupts P-body 
movement (Aizer et al. 2008). In all these studies, U2OS cells were used, which had been 
reconstituted with fluorescently tagged P-body components for live-cell imaging. U2OS cells 
are particularly well-suited for such reconstitutions. However, U2OS cells are not the ideal cell 
line to study the P-body response because they contain only very few P-bodies (2–5 per cell), 
with up to 70% of cells not harboring any detectable P-bodies. Therefore, U2OS cells proved 
unsuitable for the experiments in paper II: The P-body disassembly upon SFV infection was 
not clearly evident in U2OS cells (data not shown), in contrast to the complete disassembly of 
P-bodies in virus-infected MEFs or BHK (Paper II, Fig. 1 and S1). The cell lines employed in 
paper II contain much more P-bodies on average, MEFs around 23 P-bodies/cell and BHK 
around 15 P-bodies/cell. The reason for the variation of P-body numbers between different cell 
lines is unknown. 
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Since reconstituted cell lines such as U2OS carrying RFP-Dcp1a and GFP-G3BP1 (Kedersha 
et al. 2005) are useful to study the communication between P-bodies and SGs, we performed 
preliminary live-cell imaging experiments with these cells and observed active movement of 
P-bodies and SGs and physical contact between them during SFV infection (unpublished data). 
We also attempted to establish reconstituted MEFs or BHK cells with RFP-Dcp1a as P-body 
marker for live-cell imaging studies. However, MEFs and BHK are both less tolerant than 
U2OS to such a modification. Furthermore, expression of exogenous Dcp1a turned out to be 
harmful and led to cell death of MEFs or BHK cells (unpublished data). Overall, a suitable 
reconstituted cell line for the purpose of live-cell imaging will be beneficial for investigation 
of P-body dynamics during infection. 
P-bodies have been suggested to play important roles in the regulation of cellular translation. 
Some translation-related factors, such as initiation factor eIF4E and its transporter 4E-T, have 
been found accumulated in P-bodies (Andrei et al. 2005, Ferraiuolo et al. 2005). Interaction 
between eIF4E and 4E-T reduces the binding of eIF4E to eIF4G, leading to translation 
repression (Kubacka et al. 2013, Igreja et al. 2014). Recent studies revealed that P-body 
assembly requires the translation repression complex (Ayache et al. 2015) and DDX6–4E-T 
interaction, which also results in translation repression (Kamenska et al. 2016). Alphavirus 
infection leads to host translation shutoff, but different mechanisms have been suggested 
(Carrasco et al. 2018). Our previous studies have described that host translation shutoff is 
dominantly mediated through phosphorylation of eIF2a during Old World alphavirus infection 
(McInerney et al. 2005). In paper II, we used ribopuromycylation (David et al. 2012, Panas et 
al. 2015a) and found that efficient shutoff of host translation upon SFV or CHIKV infection 
was only observed in MEFs-SS, but not in MEFs-AA (Fig. 9B), strongly supporting our 
previous finding.  
RNA is one of the essential components for P-body assembly, as P-bodies are disassembled 
when cellular RNA is depleted with RNAse treatment (Sen and Blau. 2005) or when mRNA is 
trapped in polysomes with cycloheximide treatment (Cougot et al. 2004). Cellular RNA is 
produced via transcription, a process which is manipulated during alphavirus infection 
(Garmashova et al. 2006, Breakwell et al. 2007, Garmashova et al. 2007). The transcription 
status was investigated by labeling newly synthesized RNA with bromo-UTP during infection 
of cells with SFV or CHIKV. The results show that virus infection induced host transcription 
shutoff at about the same time as disassembly of P-bodies was observed. When we assessed 
the P-body response in the context of transcription inhibition by ActD treatment, P-body 
numbers were reduced within a nontoxic period of time, but ActD treatment did not 
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disassemble P-bodies as efficiently as virus infection (Fig. 10B). Therefore, it appears likely 
that the infection-induced P-body disassembly is caused by more than just host transcription 
shutoff induced by virus infection.  
Since a lack of RNA blocks P-body assembly, we hypothesized that changing levels of 
cytoplasmic mRNA could interfere with P-body dynamics in addition to transcription 
inhibition. The antibiotics CHX and puromycin are protein synthesis inhibitors and can affect 
free mRNA levels in the cytoplasm, but through different modes of action: CHX stabilizes 
mRNA with polysomes, leading to a decrease of free mRNA in cytoplasm, while puromycin 
causes premature chain termination and mRNA release during translation, resulting in an 
increase of free mRNA in the cytoplasm (Kedersha et al. 2000). Rapid and efficient P-body 
disassembly was observed after CHX treatment (Paper II, Fig. 5 (a); Fig. 11). However, CHX 
treatment is unlikely to reflect how P-body disassembly happens during viral infection. Not 
only does CHX cause disassembly of P-bodies, but it also effectively blocks induction of SGs, 
as a result of reducing free mRNA. If P-bodies were disassembled by the same mechanism 
during viral infection, SGs would not be induced after infection, but it is known that they are, 
which was again confirmed in paper II. It is conceivable but speculative that virus infection 
somehow makes mRNA selectively unavailable for the formation of P-bodies while not 
affecting their propensity to move into SGs.  
When P-bodies were assessed in response to puromycin treatment, no clear change was 
observed within a short period of puromycin treatment (2h), while a longer treatment almost 
eliminated P-bodies (Paper II, Fig. S5 (a)). In contrast, puromycin can elevate mRNA levels in 
the cytoplasm and contribute to the increase of P-bodies upon stress (Kedersha et al. 2000). 
Here, in the absence of stress, the disassembly of P-bodies after 4h of puromycin treatment 
most likely indicates that dynamics of P-bodies are related to translation status. 
We hypothesized that virus-induced transcription shutoff could indicate potential damages of 
nuclear transport, which might in turn affect P-body numbers. In order to investigate whether 
nuclear transport may be involved in P-body disassembly, several selective inhibitors of 
nuclear transport were used. When importin-mediated nuclear import was blocked with 
importazole (Soderholm et al. 2011), P-bodies were largely disassembled (Fig. 11; Paper II, 
Fig. 5 (a)), while a block of CRM1-mediated nuclear export with leptomycin B (Nishi et al. 
1994, Kudo et al. 1999) did not affect P-bodies (Paper II, Fig. S5 (b)). Thus, intact nuclear 
import processes appear to be important to maintain P-bodies, while nuclear export seems to 
be less relevant. These data reveal nuclear import as a novel P-body regulation pathway, which 
needs to be explored further. 
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Nuclear import might be modulated during virus infection and contribute to virus-induced P-
body disassembly. It remains to be determined by what mechanism alphavirus infection 
interferes with nuclear import to affect P-bodies. Alphavirus infection has already been shown 
to manipulate nuclear import. During infection of Venezuelan equine encephalitis virus 
(VEEV), various receptor-mediated nuclear import processes are blocked by the viral capsid 
protein (Atasheva et al. 2008). Another hint for nuclear transport modulation originates from 
the observation that many nuclear proteins are redirected to and stocked in the cytoplasm during 
SINV infection (Sanz et al. 2015). 
In summary, paper II shows for the first time that alphavirus infection leads to efficient 
disassembly of P-bodies early after infection, possibly helping the virus to establish infection. 
We identified virus-induced inhibition of host cell transcription and translation plus nuclear 
import inhibition as potential mechanisms by which virus infection could interfere with P-
bodies. Nuclear import is a novel mechanism of P-body regulation.  
Paper III 
In this work, we investigated the molecular requirements for alphavirus-induced 
hyperactivation of the PI3K–Akt–mTOR pathway, an important cellular signaling pathway to 
promote survival. We identified the key tyrosine residue Y369 in the context of a YXXM motif 
in nsP3 of SFV to be responsible for this phenotype through interaction with the regulatory 
subunit p85 of PI3K. We also show that a YXXM motif is functionally present in nsP3 of the 
important human pathogen RRV to mediate PI3K–Akt–mTOR hyperactivation, with relevance 
for pathogenesis.  
The interaction between p85 and nsP3 of SFV and RRV is a newly discovered feature of nsP3 
HVD – a protein region that binds several cellular factors and can be considered to be a hub 
for molecular interactions: the proline rich region has been shown to bind amphiphysin 
(Neuvonen et al. 2011); FGDF motifs interact with G3BP (Paper I, (Panas et al. 2015b)). Such 
interactions between the nsP3 HVD and cellular proteins play significant roles in viral growth 
and replication. SFV infection was attenuated by one order of magnitude upon point mutation 
of the single tyrosine in the YXXM motif, which indicates its high relevance for virus growth, 
similar to that of other interaction motifs in the HVD such as the FGDF motifs (see Paper I).  
According to the well-studied interaction mode between p85 and YXXM motifs, the SH2 
domains of p85 recognize phosphorylated tyrosine in the sequence context YXXM (Shoelson 
et al. 1993, Songyang et al. 1993, Waksman et al. 1993). In line with this binding mode, the 
results in paper III show that the interaction between p85 and SFV nsP3 is dependent on both 
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the SH2 domains of p85 and the YXXM tyrosine in nsP3: mutation of either of the two features 
disrupted the molecular interaction. Replacement of the YXXM tyrosine by phenylalanine – 
which has the same structure as tyrosine except for the absence of the phosphorylatable –OH 
group – was enough to abolish the nsP3–p85 interaction and the PI3K–Akt–mTOR 
hyperactivation phenotype. Even though we have not chemically shown that the YXXM 
tyrosine in SFV nsP3 is phosphorylated, our results strongly suggest that this tyrosine most 
likely is phosphorylated, at least to some degree during certain periods of time after infection, 
probably in a transient manner. This might be the reason why tyrosine phosphorylation of SFV 
nsP3 has never been reported in biochemical studies (Peränen et al. 1988; Vihinen and 
Saarinen. 2000). It remains to be determined which cellular kinases catalyze phosphorylation 
of the tyrosine in SFV nsP3 and how their activity is regulated during infection. While 
membrane targeting of nsP3 is required, the enzymatic activities of the other viral proteins are 
dispensable for tyrosine phosphorylation and PI3K–Akt–mTOR hyperactivation since 
expression of Myr-Pal-nsP3-wt (but not -YF) was sufficient to induce the phenotype. A proper 
position of the YXXM motif however appears to be relevant, based on the results from SFV-
Δ50, which does not hyperactivate PI3K–Akt–mTOR even though the YXXM motif is intact. 
It is conceivable that phosphorylation of some serines and theronines in the region that is 
deleted in SFV-Δ50 or some other features of this region may be required to allow 
phosphorylation of the YXXM tyrosine. Most likely, the deletion of the 50 residues 
immediately preceding Y369 causes steric hindrance of the YXXM motif in SFV-Δ50 and 
prevents phosphorylation of the tyrosine and/or access of p85.  
The YXXM motif is not conserved in all alphaviruses. Sequence analysis of nsP3 of all 
alphaviruses shows that YXXM motifs are only identified in SFV, RRV and very few other 
alphaviruse nsP3: Getah virus (GETV) and Sagiyama virus, which are equine pathogens in 
Asia (Fukunaga et al. 2000), as well as Middelburg virus, which mainly infects sheep, goats 
and horses in Africa (Attoui et al. 2007). We hence predict these viruses to induce PI3K–Akt–
mTOR hyperactivation as well. YXXM motifs are however absent in CHIKV and many other 
arthritogenic Old World alphaviruses as well as the New World alphaviruses. CHIKV (and 
likely the other alphaviruses lacking a functional YXXM motif) only moderately activate 
PI3K–Akt–mTOR.  
It is unlikely that the presence of YXXM is connected to vertebrate host specificity. RRV 
infects humans and causes clinically relevant disease, while SFV does not, and the other 
alphaviruses with YXXM motifs in nsP3 mainly infect horses. Other alphaviruses that are 
pathogenic for humans (e.g. CHIKV) or horses (New World alphaviruses), respectively, 
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however do not contain the motif. The presence of YXXM might however be related to vector 
competence. RRV has been isolated from more than 40 different mosquito vectors belonging 
to the genera Culex and Aedes, and can be considered a “vector generalist” (Claflin and Webb. 
2015). Little is known about SFV vectors in nature, but the virus is known to cause persistent 
infection in Aedes and Culex cell lines based on laboratory studies (Davey and Dalgarno. 1974, 
Davey et al. 1979). Alphaviruses without YXXM seem to be more restricted regarding their 
arthropod vectors. CHIKV, for instance, is carried by Aedes aegypti and Aedes albopictus, but 
not Culex mosquitoes (Pialoux et al. 2007). Perhaps PI3K–Akt–mTOR hyperactivation 
somehow helps the virus to establish persistent infection in a wider variety of anthropod hosts, 
which may be beneficial for virus spread – and potentially challenging for public health. 
The PI3K–Akt–mTOR pathway is also targeted and exploited by other viruses using different 
strategies. Some viruses inhibit the pathway during infection (Avota et al. 2001, Dunn and 
Connor. 2011), while others, such as herpes simplex virus (Strunk et al. 2016) and influenza A 
virus (IAV) (Hale et al. 2006), activate the pathway. Interestingly, a similar – but not identical 
– molecular phenotype as the one described in paper III for SFV and RRV was observed for 
IAV, a segmented negative-strand RNA virus unrelated to alphaviruses: A conserved tyrosine 
in a YXXM-like motif in the nonstructural protein 1 (NS1) of IAV was shown to be responsible 
for binding of p85-β (but not p85-α) and activation of the PI3K–Akt–mTOR pathway. In 
addition, PI3Ks can also be activated by proline-rich domains, which can be recognized by the 
SH3 domain of p85. Of note, there is a proline-rich region in the HVD of alphavirus nsP3 as 
well, but deletion of this region in SFV does not markedly affect the PI3K–Akt–mTOR 
hyperactivation phenotype (Thaa et al. 2015). We cannot exclude a potential contributing role 
of the proline-rich motif in alphavirus nsP3 for PI3K–Akt–mTOR activation. However, the 
YXXM tyrosine is clearly the dominant feature for p85 binding and PI3K–Akt–mTOR 
hyperactivation by SFV and RRV.  
Paper III provides functional implications of the PI3K–Akt–mTOR hyperactivation phenotype. 
A very important downstream effect of PI3K–Akt hyperactivation is the sustained activation 
of mTOR, even under conditions of complete nutrient and growth factor starvation. Activation 
of mTOR promotes synthesis of proteins and lipids and keeps cells in a state of normal growth, 
which might ensure viral proliferation even under adverse conditions. Furthermore, 
metabolomics revealed an up-regulation of glycolysis upon infection with SFV-WT, which is 
connected to PI3K–Akt–mTOR hyperactivation because it was sensitive to the PI3K inhibitor 
wortmannin and much less pronounced with SFV-YF. The metabolic changes upon SFV-WT 
infection led to increased levels of fatty acids, amino acids and nucleotides, which all serve as 
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building blocks for progeny virions. Similar effects on glycolysis were also observed with 
RRV. These results suggest that a major effect of PI3K–Akt–mTOR hyperactivation concerns 
metabolism. The results of the in vivo infection experiment with RRV in mice, showing 
attenuation of RRV-YF compared to RRV-WT, indicates that PI3K–Akt–mTOR 
hyperactivation is relevant for virulence, likely because of metabolic effects, but potentially 
due to other additional mechanisms. 
The PI3K–Akt–mTOR pathway has been linked to many cellular processes, including SGs 
(Nitulescu et al. 2016, Heberle et al. 2019). A recent study has shown that activation of PI3K 
and mTOR promotes SG formation under stress (Heberle et al. 2019), which resembles the 
events upon SFV-WT infection, where the PI3K–Akt–mTOR pathway is hyperactivated (paper 
III) and SGs are induced at early stages of infection (McInerney et al. 2005). However, the 
PI3K–Akt–mTOR hyperactivation seen with SFV and RRV, dependent on the YXXM motif 
in nsP3, is largely unrelated to the induction or modulation of SGs. Alphavirus-induced SG 
formation proceeds by translation shutoff caused by infection-induced eIF2α phosphorylation 
early in infection (McInerney et al. 2005). With alphavirus infection, eIF2α is phosphorylated 
by dsRNA-activated protein kinase R (PKR), which is probably not linked to the PI3K–Akt–
mTOR pathway. Likely, SFV-YF also induces SGs upon infection by generation of dsRNA. 
Further, virus-induced SGs are later counteracted by the FGDF-motif-mediated interaction of 
nsP3 with G3BP (Panas et al. 2012, Panas et al. 2015b), which is likely conserved between 
SFV-WT and SFV-YF due to the presence of two intact FGDF motifs. Moreover, SFV-
delta789, the nsP3 of which does not interact with G3BP, hyperactivates PI3K–Akt–mTOR to 
the same extent as SFV-WT (Thaa et al. 2015). Upon infection of SFV-WT or SFV-YF, P-
bodies were similarly disassembled (data not shown), although the PI3K–Akt–mTOR pathway 
is activated to different levels. Lastly, SG modulation and G3BP binding (see paper I) and P-
body disassembly (see paper II) are conserved between SFV and CHIKV, while the PI3K–
Akt–mTOR hyperactivation phenotype is not (Thaa et al. 2015). In summary, virus-caused 
PI3K–Akt–mTOR hyperactivation is unlikely related to the responses of SGs or P-bodies upon 
alphavirus infection (Table 1). 
Potential connections between the PI3K–Akt–mTOR pathway and SGs and/or P-bodies in cells 
may exist, but these connections are unlikely to be relevant in alphavirus infection and are 
much weaker than the viral effects on either of these pathways as characterized in this thesis. 
The effects of alphaviruses on SGs/G3BP, P-bodies and the PI3K–Akt–mTOR pathway can be 
seen as mostly separate principles (Table 1), each of which is exploited by the virus to ensure 
efficient establishment of infection and efficient growth. 
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 Interaction 
with G3BP 
SG counteraction P-body disassembly PI3K–Akt–mTOR 
hyperactivation 
SFV-WT Pa Pa Pb Pc 
SFV-F3ANC Oa Oa Pd Pc 
SFV-YF Pe Pe Pd Oc 
Table 1: Feature summary of SFV-WT, -F3ANC, -YF regarding interaction with G3BP, SG counteraction, 
P-body disassembly and PI3K–Akt–mTOR hyperactivation. (P): positive. (O): negative. a: shown in paper I 
and (Panas et al. 2012, Panas et al. 2015b); b: shown in paper II; c: shown in paper III and (Thaa et al. 2015); d: 
data not shown; e: not determined, but highly likely based on the molecular mechanism of G3BP interaction 
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4 FUTURE PERSPECTIVES 
The work described in this thesis characterized three separate mechanisms of how alphaviruses 
interfere with the host cell to establish infection: binding of the two FGDF motifs in nsP3 to 
the SG nucleating protein G3BP (paper I), disassembly of P-bodies (paper II) and 
hyperactivation of the PI3K–Akt–mTOR pathway by interaction of a YXXM motif in nsP3 of 
SFV and RRV with the p85 subunit of PI3K (paper III). The results in papers I and III 
demonstrate two specific virus–host interactions in molecular detail and characterize their 
functional importance for the virus at different levels. In paper II, a novel virus–host interaction 
was discovered and characterized. 
Paper I 
In paper I, the FGDF-mediated interaction of nsP3 with G3BP was scrutinized for SFV and 
CHIKV. The FGDF-mediated interaction of nsP3 with G3BP seems to be conserved across the 
Old World alphaviruses, while the details of this interaction and the subsequent functional 
sequences may differ among different virus species. The HVD of nsP3, the protein domain 
where the FGDF motifs are situated, varies greatly between the alphavirus species and even 
between strains of the same virus. In respect to the binding to G3BP, the surrounding of the 
two FGDF motifs may matter, as seen in paper I for the comparison between SFV and CHIKV. 
In addition, the two FGDF sequences are not fully conserved in all Old World alphaviruses. 
For instance, the second FGDF in nsP3 of RRV is replaced by the sequence FGDIDF. Given 
the functional importance of the interaction with G3BP, it is very likely that nsP3 of RRV binds 
to G3BP in a very similar manner as nsP3 of SFV or CHIKV. But the interaction details and 
subsequent potential impact on virus growth remain unknown, which is worth to be 
investigated. 
Another open issue concerns the difference between the two isoforms of G3BP, G3BP1 and 
G3BP2, which has been investigated only poorly (Tourriere et al. 2003). Most studies focus on 
either of these isoforms and treat them as backup for each other with redundant functions. It is 
not easy to study only one of the isoforms individually, as single knockdown of either G3BP1 
or G3BP2 results in the increase of the other one (Matsuki et al. 2013). In our studies, we 
observed potentially relevant differences between G3BP1 and G3BP2: Both FGDFN and 
FGDFC bound G3BP2 to equal extents, in contrast to the binding to G3BP1. Moreover, virus 
infection accelerated the degradation of G3BP2 but not G3BP1 (data not shown). These results 
suggest that FGDF motifs may have different binding preferences for G3BP1 and G3BP2. 
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More studies should be conducted to differentiate the roles and functions of the G3BP isoforms, 
in alphavirus infection and beyond.  
The roles of G3BP in alphavirus infection have not been fully elucidated. The results of paper 
I suggest that G3BP plays an active role in the viral RCs. Such studies have been done in our 
group to investigate the role of the domains of G3BP to promote efficient translation in viral 
replication complexes (Götte et al. 2019). 
The FGDF-mediated interaction may be an attractive target for therapeutic intervention, since 
it is so important for alphaviruses infection. CHIKV, for instance, is unable to replicate if there 
is no interaction of nsP3 and G3BP (paper I). Thus, blocking the interaction with some small 
molecule inhibitor or peptide-based agent may inhibit virus replication. 
Paper II 
In paper II, the timing and extent of alphavirus-induced P-body disassembly was characterized, 
and some hints to possible mechanisms were suggested (transcription and translation 
inhibition, nuclear import). This needs to be explored further. 
Knowledge on what elements of the virus are responsible for P-body disassembly would 
facilitate the mechanistic studies of virus-induced P-body responses, as well as P-body 
dynamics. Our results show that viral structural proteins are dispensable for alphavirus-induced 
P-body disassembly (Fig. 6B), while expression of nsPs, even though functional virus replicase 
is formed, is not sufficient (Fig. 7). The trans-replication system is a convenient but somewhat 
artificial system, which could however still be useful for further studies. In contrast to the virus 
and SFV-bGal, a reporter gene, instead of the “real” virus genes for nsPs, is replicated by the 
viral replicase in the trans-replication system. This difference could result in defects in replicase 
regulation and subsequently aberrant replication in the trans-replication system. To minimize 
this difference, the reporter gene could be replaced with full length genes for nsPs, to resemble 
the events during SFV infection more faithfully. The experiment could be further extended by 
replacing the reporter gene with genes for various combinations of nsPs, e.g nsP12, nsP123, 
nsP23. The results of such experiments would shed more light on how P-bodies respond to 
various combinations of nsPs and help to identify what elements of the virus are responsible 
for P-body disassembly. 
The results of paper II reveal and highlight the importance of nuclear import for P-body 
dynamics. This warrants closer investigation. There may be cellular factors involved in nuclear 
transport, such as importins and Ran GTPases, that might be targeted by the virus. 
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Immunoprecipitation and proteomics studies could be helpful to identify interaction partners 
with potential relevance for P-body disassembly.  
Recently, there have been significant technical advances in labelling and tracking of RNA 
(Horvathova et al. 2017, Tutucci et al. 2018). It would be interesting to apply these techniques 
for P-body studies after infection. Such studies would require triple labeling in live cells for 
random RNA, P-bodies and virus. Such an imaging study in live cells would generate 
interesting information regarding how infection modulates cellular RNA and how P-bodies 
respond to virus infection. Specifically, the hypothesis could be tested that at early stages of 
infection, the virus may cause rapid degradation of cytoplasmic mRNA in the periphery of P-
bodies, leading to the disassembly of the granules. Live-cell imaging will probably provide 
more information, considering that P-bodies are highly dynamic structures. 
Lastly, it is currently unclear whether P-bodies could be exploited as an antiviral strategy. 
Stabilizing P-bodies or preventing their disassembly might restrict virus replication. But first, 
more research is needed to better understand P-body dynamics and the viral strategies to 
interfere with P-bodies. 
Paper III 
In paper III, the molecular mechanism of PI3K–Akt–mTOR hyperactivation upon SFV and 
RRV infection was characterized in molecular detail. The study revealed that these viruses 
exploit a well-known cellular interaction mechanism, the binding of the SH2 domains of p85 
to phospho-tyrosine in a YXXM motif. The PI3K–Akt–mTOR hyperactivation alters cellular 
metabolism and possibly affects other signaling pathways.  
The PI3K–Akt–mTOR hyperactivation phenotype is not conserved across the Old World 
alphavirus, unlike the FGDF-motif-based interaction of nsP3 with G3BP (paper I) or the P-
body disassembly phenotype (paper II). The relevance of PI3K–Akt–mTOR hyperactivation is 
thus limited to some specific alphaviruses. However, the knowledge about the PI3K–Akt–
mTOR hyperactivation phenotype may be helpful to design SFV-based viral vectors for gene 
therapy or vaccines. Hyperactivation of PI3K–Akt–mTOR could be either beneficial or 
harmful to the target cells depending on the circumstances, thus either SFV-WT or SFV-YF 
should be selectively applied.   
The PI3K–Akt–mTOR pathway is also activated by alphaviruses that do not carry a functional 
YXXM motif (SFV-YF, RRV-YF, CHIKV), albeit to a lesser extent. This “basal” activation 
of the pathway is weaker and slower and can be inhibited by nutrient and growth factor 
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starvation (paper III, (Thaa et al. 2015)). The mechanisms and functions of this “basal” 
activation have not been determined, but warrant closer investigation. It is unclear whether this 
“basal” activation is just a cellular response to virus infection at later stages or whether it is 
actively modulated by the virus. In the latter case, the “basal” activation of this cellular survival 
pathway may be relevant for virus growth and may thus represent a potential therapeutic target. 
Concluding remarks 
This thesis describes three principles by which alphaviruses modulate mammalian host cells. 
As arboviruses, alphaviruses have another host – the insect vector. Some of the mechanisms 
described in this thesis may also be relevant in insects or may even have evolved in the insect 
host. Future research should therefore investigate these mechanisms in insects as well. It has 
been shown that nsP3 binds to the insect homolog of G3BP termed “Rasputin” (Fros et al. 
2015), while alphavirus interactions with P-bodies in insects have not been described. 
Modulation of the PI3K–Akt–mTOR pathway in insects might be relevant in terms of 
persistence and vector competence. 
The results presented in this thesis hopefully build the basis for follow-up research to learn 
even more about alphavirus and host cell biology. 
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